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1 ABSTRACT 
NUMB was originally identified as a cell fate determinant that controls signaling outputs 
during asymmetric cell division. NUMB is a tumor suppressor protein that regulates 
NOTCH and p53 signaling pathways. Loss of NUMB occurs in 50% of all breast tumors 
and in 30% of lung cancers, and correlates with an increased aggressiveness and poor 
prognosis.  
NUMB has been also characterized for its role in trafficking, acting as an adaptor protein 
and regulating signaling emanating from various plasma membrane receptors, including 
NOTCH, Receptor Tyrosine Kinases (RTKs), such as EGFR and c-MET, and integrins. 
Consistent with this latter notion, NUMB interacts with key players of the Clathrin-
mediated endocytosis, regulating the internalization of various receptors. However, its 
action cannot be restricted to the initial steps of internalization at the level of the cell 
surface, as it also localizes, in C. Elegans and D. Melanogaster, in recycling endosomes 
and regulates the delivery of cargos back to the plasma membrane. Similarly, in 
mammalian cells, NUMB and EH (Eps15- Homology)-domain containing proteins co-
localize in ARF6-associated recycling vesicles, and NUMB regulates post-endocytic 
sorting of NOTCH1. 
The combination of endocytic/recycling trafficking and actin related dynamics is one of the 
major mechanisms through which spatial restriction of signaling is achieved. Indeed, the 
correct recycling of active RAC via ARF6 to the plasma membrane is required for the 
formation of migratory protrusions induced upon RTK stimulation, such as Circular Dorsal 
Ruffles (CDRs). 
To identify novel endocytic/trafficking proteins involved in actin dynamics and directional 
cell migration, we performed an RNAi screening using Peripheral Ruffles (PRs) and CDRs 
as readout markers. We found that the endocytic adaptor NUMB is as a negative regulator 
of CDR formation without affecting PR formation.  
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In this thesis, we have characterized NUMB as a negative regulator of CDR formation 
downstream of c-MET and PDGFR. This function of NUMB is accompanied by an 
increased mesenchymal mode of motility and cell invasion. In agreement with the notion 
that spatial recycling of active RAC to the plasma membrane mediated by ARF6 is 
required for the formation of CDRs, we found that NUMB is enriched in ARF6 recycling 
compartments and inhibits MHC I and RAC recycling. These evidences suggest that 
NUMB might act as a negative regulator of ARF6-dependent recycling. Since GEFs are 
the primary regulatory targets of small GTP-ase, we focused our attention on ARF6 GEFs, 
which are reported to control actin remodeling, in particular on the EFA6A-D and 
Cytohesin family members. Among these GEFs, only EFA6B contains an NPxF motif in 
its N-terminal domain and directly binds the NUMB PTB domain. Functionally, the 
removal of EFA6B by itself does not alter CDR formation, but it inhibits the increase of 
CDR formation that is brought about by NUMB down-regulation. Whether NUMB affects 
EFA6B GEF activity and, as a consequence, ARF6 activation, is currently under 
investigation. 
Our data suggest that NUMB may regulate the ARF6-dependent recycling pathway, which 
is required for migration and invasion of tumor cells, by interacting with and possibly 
modulating its GEF EFA6B. Of note, up-regulation of this pathway in the absence of 
NUMB may even account for the aggressiveness of NUMB-negative tumors.  
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2 INTRODUCTION 
This thesis describes the molecular mechanism through which the endocytic protein 
NUMB regulates spatially and temporally defined signaling. The introduction is divided 
into three main topics that cover my work: endocytosis and spatial restriction of signaling, 
the endocytic adaptor NUMB, and the small GTP-ase ADP-ribysilation factor (ARF) 
protein family. First, I will provide an overview of how endocytosis and spatial restriction 
of cell signaling are connected. In section 2.1, I will briefly describe endocytic mechanisms 
and how the mode of internalization affects signaling output and endosome-mediate 
signaling (section 2.1.1 and 2.1.2). Then, I will describe the crosstalk between endocytosis 
and recycling in the light of regulated signaling in space and time (section 2.1.3). In the 
second part of the introduction, instead, I will describe the NUMB protein family (section 
2.2.1): NUMB biological function (section 2.2.2), NUMB regulated pathways (section 
2.2.3), and NUMB alterations and their implication in cancer. Finally, in the last part of the 
introduction, I will describe the ARF protein, focusing on ARF6, its family of guanine 
nucleotide exchange factors (GEFs), and on the PSD (EFA6) family (section 2.3).
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2.1 Endocytosis and spatial restriction of cell signaling 
By definition, endocytosis is the process by which eukaryotic cells actively transport 
molecules from the extracellular environment across the cell membrane. In this way cells 
can intake not only fluids and soluble molecules (like nutrients, ligands, lipids), but also 
internalize portions of plasma membrane (PM) and surface receptors(Doherty and 
McMahon 2009; Scita G 2010).  
Cell surface receptors can internalize via two main pathways of endocytosis: Clathrin-
mediated endocytosis (CME) and Non-clathrin-mediated endocytosis (NCME)(Doherty 
and McMahon 2009; Conner SD 2003) (Fig. 1). 
 
Figure 1. Endocytic pathways of signaling receptors.  
The figure describes CME and NCME trafficking routes. During CME (left), upon binding of a soluble 
ligand, RTK receptors are internalized into clathrin-coated vesicles by adapting proteins, like AP-2 and 
dynamin. Many forms of NCME (right) exist and one of this occurs in the area of the PM that is 
enriched in particular lipids (lipids raft). After internalization, either through CME or NCME, cargos are 
delivered to early endosomes. From the early endosomes, receptors can be recycled back to the PM 
either through a fast or a slow recycling route, or through the ARF6-dependent pathway. From the early 
endosomes, ubiquitilated proteins are transported to late endosomes and multivesicular bodies, and 
finally to the lysosome to be degraded.  
Modified from(Scita G 2010). 
In CME, ligand binding to the receptor is followed by the recognition of cytoplasmic 
domains of PM proteins by specific adaptor proteins (such as AP-2 and the GTPase 
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dynamin), which pack them into clathrin-coated vesicles that are then delivered into the 
cells. The iron-bound transferrin receptors (TfRs) and low-density lipoprotein receptors 
(LDLRs) are two examples of receptors that are internalized into the cytosol via the 
CME(Conner SD 2003; Doherty and McMahon 2009). NCME exists in many forms; for 
example, macropinocytosis and phagocytosis are actin driven(Mayor and Pagano 2007; 
Sandvig K 2008), and lipid rafts are lipid microdomains enriched in sphingomyelin and 
cholesterol(Simons and Ikonen 1997). Lipid rafts contain caveolin-1, a protein that 
associates with cholesterol and sphingomyelin, and form particular structures called 
caveolae.  
Despite the route used to enter the cells, all cargos are delivered to early endosomes (EE). 
Trafficking to the endosomal compartment is regulated by small GTP–binding proteins of 
the RAB and ARF families(H 2009). From EE, cargos can be recycled back to the PM by 
a fast RAB4-dependent recycling pathway or by a slow RAB8- and RAB11-dependent 
recycling pathway(H 2009). Moreover, proteins internalized through the NCME, like 
MHC class I, can be recycled to the PM via ARF6(JG 2005). From EE, ubiquitilated 
proteins are transported via RAB7 to late endosomes (LE) and multivesicular bodies 
(MVBs), and then to the lysosome(H 2009) (Fig. 1).   
Endocytosis is recognized as a way to regulate signal transduction from Receptor 
Tyrosine Kinases (RTKs) and G protein-coupled receptors (GPCRs)(Conner SD 2003). 
In fact, by controlling the number of receptors on the cell surface, either by using a 
trafficking route that leads to degradation or by regulating the activation of downstream 
effectors, cells are able to generate different and specific responses to extracellular cues. 
Eukaryotic cells have the ability to sense spatial information by modifying their 
cytoskeleton and their membrane composition. More importantly, cells organize their 
signaling machinery in a way in which molecules are asymmetrically distributed and the 
output signal is spatially restricted(Disanza et al. 2009).  
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Cells not only arrange the signal into endosomal platforms, but also use different way to 
reach different compartments(Sorkin A 2009). Upon internalization, proteins are often 
recycled back to the PM to replace unbound receptors for a new round of signaling and 
transport. Moreover, the recycling can also be seen as a mean to direct signaling 
molecules to specific areas of the PM, like the apical and basal membrane of polarized 
epithelial monolayer(Lecuit T 2003), or as a mean to maintain polarized molecules, like 
the small GTPase CDC42 during the generation of buds in yeast(Marco E 2007). 
Endocytosis of molecules is also followed by internalization and recycling of the PM, 
generating constant membrane flow. This flow of membrane is required to generate 
forces that sustain the formation of migratory protrusions(Bretscher MS 1998) or to 
promote the backward movement of molecules during the formation of protrusions in cell 
migration(Bretscher MS 1998). 
CME has been shown to control cell shape in different migratory cells(Palamidessi et al. 
2008), supporting the existence of a link between membrane dynamics, cell shape 
changing and polarized signaling. All these evidences support a role for endocytosis in 
spatial restriction of signaling outputs. 
2.1.1 Signaling outputs are affected by the internalization route 
Generally, receptors are kept off from the cell surface upon ligand binding. This event is 
critical to allow receptor activation and the assembly of macromolecular complexes 
required to transmit and amplify the signaling. Once activated, the receptors are 
immediately internalized and either delivered to degradative compartments to decrease 
the continuous signaling or recycled back to the PM(Disanza et al. 2009).  However, 
signal transduction is not limited to the surface but can also occur while the receptor is 
internalized. Downregulation of cell surface receptors occurs mainly though the CME but 
different receptors are also internalized by NCME(Disanza et al. 2009). For example, 
platelet-derived growth factor receptors (PDGFRs) and epidermal growth factor receptors 
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(EGFRs) are sequestered by caveolae that immobilize the receptors and prevent their 
over-activation(Matveev and Smart 2002). Sequestration of molecules into lipid 
microdomains is also true for non-receptor tyrosine kinases, for example c-src, which is 
confined and inactivated into microdomains that are unable to give rise to signal 
transduction and transformation(Oneyama et al. 2008; Veracini et al. 2008). Biological 
outcome, extent, duration and localization of the signaling are strictly dependent on the 
mode of internalization(Sadowski, Pilecka, and Miaczynska 2009) (Fig. 2). For example, 
the TGFB and EGF receptors can be internalized either via CME or NCME. When these 
receptors are internalized via CME, they are efficiently recycled back to the PM to 
amplify and spatially restrict the signal, especially in the case of directional migration and 
chemotaxis(Le Roy and Wrana 2005) (Fig. 2A). On the other end, NCME mainly directs 
the receptors to degradation by targeting them with ubiquitin(Di Guglielmo et al. 2003; 
Sorkin A 2009), suggesting that this posttranslational modification maybe fundamental to 
receptor fate (Fig. 2A). Recently, it has been shown that other cargos, like the WNT3A 
and the low-density receptor-related protein 6 (LDL6) receptors, use the endocytic 
pathway in an opposite manner(Kikuchi, Yamamoto, and Kishida 2007; Yamamoto et al. 
2008) (Fig. 2B).  
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Figure 2. Signaling outputs are affected by the way in which receptors are internalized.  
A. EGFR and TGF-ß-R, when internalized via CME, are efficiently recycled back to the PM to sustain 
cell signaling. When internalized via NCME, instead, receptors are delivered to degradation 
compartments to attenuate signaling. 
B. Wnt3a binds to the LPR6 receptor and is internalized via NCME to promote signal transduction. 
DKK-LPR6 complex enters the cell via CME to decrease the signaling. 
Modified from(Disanza et al. 2009).  
A peculiarity of the EGFR internalization is that the choice between CME and NCME 
depends on the ligand concentration and on the number of receptors on the cell 
surface(Sigismund et al. 2005; Sorkin A 2009). In fact, low doses of EGF promote 
internalization exclusively via CME(Sigismund et al. 2005), while high doses of EGF 
promote a mixture of CME and NCME. Under this condition the receptors are 
ubiquitinated and routed to multi-vesicular bodies for degradation(Sigismund et al. 2005; 
Sigismund et al. 2008). Ligand concentration not only modulates the duration and the 
intensity of the response but also the specificity. For example, low doses of PDGF induce 
changes in the actin cytoskeleton and the formation of migratory protrusions, which are 
CME dependent. On the contrary, high doses of PDGF induce mitogenesis and cell 
proliferation, which rely on the presence of NCME pathways(De Donatis et al. 2008). 
Ligand concentration is also important in a physiological contest. During morphogenesis, 
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some RTKs and GPCRs acts as motogenic sensors, which respond to chemotactic 
gradients that guide the migratory cells to their destination. This phenomenon occurs for 
example during the migration of primordial germ cells in the zebrafish gonad 
development(Raz 2004). Thus, CME and NCME are differentially linked to signal 
activation or downregulation, depending on the types of cargo, different ligands and the 
concentration of the ligands. 
2.1.2 Endosomes function as a signaling compartment 
Upon internalized, either through CME or NCME, sorted cargos are direct to EEs, which 
are the first sorting station in the internalization process. This compartment is marked by 
the presence of the small GTPase RAB5 and the early endosome antigen-1 (EEA1), and 
is characterized by precise protein and lipid composition(Zerial and McBride 2001). The 
pH in the EEs is about 6. From this compartment, cargos can either be routed to MBVs or 
recycled back to the PM. In the last years, the concept that EEs are specialized 
compartments where signals are originated and maintained in order to generate spatially 
and temporally restricted outputs has emerged.  
The “signaling endosome hypothesis” was initially formulated in neurons to sustain long-
range transmission of signaling(Howe and Mobley 2005). During the years, the 
“signaling endosome hypothesis” has also been extended to others cell types, thanks to 
the big increase in the development of signaling biosensors and new cell imaging live 
techniques. In fact, activated RTKs, like EGFR, and their targets, such as H-Ras, have 
been found to signal from EEs by imaging specific biosensors in the cell(Jiang and 
Sorkin 2002; Baass et al. 1995). The same tool allowed the visualization of EGF 
associated with its receptors in EEs, from which the RAS/ERK signaling takes 
place(Baass et al. 1995). 
Spatial regulation of signaling relies also on the variety of endocytic compartments. For 
instance, endosomes marked by the presence of the RAB5 effectors APPL1 and APPL2 
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are different from those marked by EEA1 and are linked to mitogenic 
signaling(Miaczynska et al. 2004).  
An example is provided by the endosomes that mediate signal transmission between the 
PM and the nucleus, like in the case of c-MET receptor and STAT3(Kermorgant and 
Parker 2008). Upon hepatocyte growth factor (HGF) binding, c-MET receptor may 
activate either ERK1/2 or STAT3. Activation of the former occurs when the receptor 
localizes in EEs but not in the perinuclear area; activation of the latter requires 
translocation of the active receptor to the perinuclear area via microtubules and protein 
kinase C (PKC)-α(Kermorgant and Parker 2008).  
Passing through the LE compartment or MVBs, cargos finally reach the lysosomal 
degradative compartment. MVBs are characterized by the presence of the lysosome-
associated membrane protein-1 (LAMP-1) and RAB7(Hurley 2008). Generally, this 
compartment is considered a place where signals are weekend(Hurley 2008), however, 
there are  few exceptions. For example, as a consequence of the presence of specific 
adaptors, MVBs contain activated receptors and promote ERK activation. This is the case 
of the late endosomal adaptors p14 and MP1, which form a complex and recruit MEK1 to 
the PM and activate ERK(Teis, Wunderlich, and Huber 2002). 
All these examples support the concept that endosomes are intracellular, spatially 
confined platforms, and an additional step in the control of biological response to 
extracellular cues.   
2.1.3 Endocytosis/recycling cross-talk spatially restricts the signals controlling 
proliferation and cell fate determination, actin-based cell migration and cell 
adhesion 
Upon being internalized, receptors that are not routed to degradative compartments are 
recycled back to their sites of origin. The endosomal recycling pathway is composed of 
different types of endosomes: the early sorting endosome (EE), the endocytic recycling 
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compartment (ERC), and the ADP ribosylation factor-6 (ARF6) dependent recycling 
compartment, which include integral membrane proteins that are internalized via 
NCME(Donaldson and Honda 2005). The ERC is also characterized by many regulatory 
components, including RABs, which control several steps in the intracellular membrane 
trafficking(Zerial and McBride 2001).  
A growing number of evidences suggests that the endocytosis/recycling of membrane 
bound proteins is strictly connected to signaling, controlling its intensity and specificity. 
Of course, spatial restriction of signaling is required to carry out a number of fundamental 
cellular functions that are defined by an “asymmetric and polarized” distribution of 
molecules and functional activities.  
In the following section I will describe examples of how endocytosis/recycling controls 
localized intracellular responses to different stimuli, resulting in spatial restriction of 
polarized signals. 
2.1.3.1 Recycling re-sensitize desensitized receptors by endocytosis 
The endocytic recycling pathway controls the levels and the activity of GPCRs(Hanyaloglu 
and von Zastrow 2008). Several studies demonstrate that the rapid desensitization is 
mediated by the coupling of receptor phosphorylation and internalization. In agreement 
with this notion, agonist-bound receptors initiate signaling by the activation of G proteins 
at the PM, and quickly undergo phosphorylation by GPCR kinases that phosphorylate 
agonist-activated receptors(Hanyaloglu and von Zastrow 2008). Once phosphorylated, the 
receptors bind the adaptor proteins ß-arrestin-1 and ß-arrestin-2 to prevent the interaction 
of the receptor with G-protein, and terminate, thus, G-protein mediated 
signaling(Hanyaloglu and von Zastrow 2008). Arrestins can also bind to clathrin, thereby 
promoting CME of arrestin-bound receptors, contributing to their desensitization. Delivery 
of internalized receptors into a recycling pathway promotes the return of intact receptors to 
the PM and effectively re-sensitize cells to respond again to extracellular ligands. This 
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cycle of desensitization/re-sensitization(Disanza et al. 2009) has important implication also 
in the specification of the nature of the resulting signaling(Disanza et al. 2009). 
2.1.3.2 Endocytosis/recycling in asymmetric cell division 
The endocytic recycling is also fundamental in the determination of cell fate and control of 
asymmetric division. Studies in the developing sensory organ of Drosophila(Coumailleau 
and Gonzalez-Gaitan 2008), as well as in other model organism(Gonczy 2008) and in 
mammalian cells(Furthauer and Gonzalez-Gaitan 2009), show that a general mechanism 
for creating asymmetric signals, in order to specify fate determination, is the polarization 
of endocytic recycling pathways(Coumailleau and Gonzalez-Gaitan 2008). Several players 
of asymmetric cell division (ACD) have been characterized(Furthauer and Gonzalez-
Gaitan 2009). In Drosophila, the endocytic protein NUMB is asymmetrically partitioned at 
the division of sensor organ precursor cells (SOP), conferring different destinies to the two 
daughter cells(Furthauer and Gonzalez-Gaitan 2009).  This function of NUMB will be 
further discussed in section 2.2.2.1. 
2.1.3.3 Endocytosis and recycling in directed cell motility 
Cell motility depends on localization of signaling molecules and their signaling. During 
locomotion, cells polarize PM proteins according to their migratory direction, which 
allows cells to orchestrate membrane trafficking, adhesion to the substrate, actin 
remodeling, and to generate propulsive forces that are required for active motility at the 
leading edge(Disanza et al. 2009).  
One mechanism that has been proposed to coordinate protrusion in directional migration of 
cells is the polarization of motogenic factors and their effectors by a flow of endocytic 
internalization of membranes, followed by re-translocation of vesicles and cargos to the 
cell front(Bretscher and Aguado-Velasco 1998b). This concept originates from the 
observation that vesicles containing recycling cargos, like LDLR and TfR, are 
concentrated towards the periphery of the cells(Bretscher 1983).  
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The endocytic/recycling pathways are critical for directional cell migration in response to 
chemotactic gradient. Studies in Drosophila demonstrated that the migration of border 
cells is controlled by the gradient of motogenic factors like EGF and PV (PDGF/VEGF), 
towards which cells move directionally(McDonald et al. 2006). In Drosophila, the 
migration of border cells depends on CBL, an E3 ubiquitin ligase, and on Spirt, an 
homologue of RAB5 GEF Rin1, indicating that endocytic pathways are required to 
guarantee spatial resolution of chemotactic signaling emanating from different RTKs, thus 
regulating actin-based polarized protrusion activity and motility(Jekely et al. 2005). 
Numerous studies support the role of endosomal recycling also in mammalian cells during 
migration. Indeed, in human KB cells (derivatives of HeLa cells)(Bretscher and Aguado-
Velasco 1998a), surface ruffles have been shown to depend on exocytosis of recycled 
membrane derived from endosomes(Bretscher and Aguado-Velasco 1998a). Other 
evidence in mammalian epithelial cells suggests that interference with RAB11-dependent 
recycling increases random motility and impaired directional and persistent migration, as a 
consequence of delocalized formation of lamellipodia(Prigozhina and Waterman-Storer 
2006). Polarized endosomal recycling is hence required for the establishment of cell 
migration polarity and perturbation of this pathway leads to disorganized cell motility. 
2.1.3.4 Spatial restriction of signaling is controlled by endocytosis/recycling during 
migration in a 3D environment 
Migratory protrusions, such as peripheral lamellipodia (PL) and circular dorsal ruffles 
(CDRs), generated by RTKs stimulation(Buccione, Orth, and McNiven 2004) are required 
for migration in three-dimensional  (3D) matrices(Suetsugu et al. 2003) (Fig. 3). The 
formation of these protrusions needs endocytic proteins and actin regulatory proteins, such 
as Dynamin and cortactin, suggesting that CDRs are sites where actin dynamics and 
endocytosis are integrated(Krueger et al. 2003; Orth and McNiven 2003).  
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Figure 3. Endocytic trafficking of RAC is required for spatial restriction of signaling in the 
control of migratory programs. 
Upon binding of HGF to C-Met, the receptor is internalized via CME in EEs that contain the small 
GTPase RAB5. In this compartment, the small GTPase RAC is activated by TIAM1, a nucleotide 
exchange factor, and is recycled back to specific regions of the PM via ARF6, where CDR and PL are 
formed. The integrin α5ß1 can associate with the small GTPase RAB25 and traffic bidirectionally 
between intracellular RAB25 vesicles and the PM within the confines of the pseudopodial tips. 
Modified from(Disanza et al. 2009). 
Moreover, a tripartite signaling cascade originating from RAB5, Phosphatidylinositol-4,5-
bisphosphate 3-kinase (PI3K) and RAC must function at the same time to allow CDR 
formation(Lanzetti et al. 2004). Conversely, a linear pathway connecting RAS, PI3K and 
RAC to actin remodeling is sufficient to generate lamellipodia protrusions in response to 
RTKs(Lanzetti et al. 2004). The endocytic/recycling trafficking of RAC is necessary for 
the generation of CDRs(Palamidessi et al. 2008). Consistently, in Hela cells, RAB5-
dependent RAC activation and CDR formation relies on clathrin and dynamin, thus, on 
endocytosis. Additionally, RAC trafficking from the PM to endocytic vesicles, containing 
RAB5 and TIAM1, is necessary for spatially confined RAC activation. Inhibition of 
recycling blocks CDR formation through RAB5 activation and HGF stimulation, 
indicating that the recycling step is required as well. Vesicles are targeted to the PM by the 
small GTPase ARF6, but not by RAB4 or RAB11(Palamidessi et al. 2008), which were 
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previously implicated in RAC trafficking(Radhakrishna et al. 1999). Moreover, ARF6 
controls also the trafficking of ß1 integrins to the PM(D'Souza-Schorey and Chavrier 
2006), suggesting that these vesicles are sites where different types of cargo are sorted and 
delivered to guarantee spatial restriction of signaling for polarized motility(Disanza et al. 
2009). From a mechanistic point of view, a question to address is how molecules are 
recycled to specific regions of the PM to generate spatially restricted signals. For example, 
upon the activation of CME(Palamidessi et al. 2008), RAC is delivered to membrane 
binding sites in lipid rafts(del Pozo et al. 2004; del Pozo et al. 2005) where its 
internalization is blocked by integrin signaling. In this context, ARF6-dependent recycling 
plays a fundamental role in delivering RAC, integrins and lipid rafts back to the PM, thus 
coordinating RAC signaling and directional migration with cell adhesion(Balasubramanian 
et al. 2007). The importance of spatial restriction of RAC signaling in the control of 
migratory protrusions is highlighted by the discovery of the correlation of CDR formation 
with the ability of the cells to acquire a mesenchymal mode of motility and migration in 
3D(Suetsugu et al. 2003), properties that are features of metastatic invading cancer cells. 
RAC signaling has also been shown to be involved in mesenchymal migration(Sanz-
Moreno et al. 2008), suggesting that endocytic/recycling pathways, by ensuring RAC 
spatial restriction and polarization, may also control the amoeboid-to-mesenchymal 
transition. For example, the ectopic expression of RAB5 in melanoma cells, a model for 
amoeboid motility, induces a switch to a mesenchymal-like mode of motility. On the 
contrary, inhibition of RAB5 in colon carcinoma cells, a model for mesenchymal motility, 
induces a switch to an amoeboid-like mode of motility(Palamidessi et al. 2008). Of note, 
RAB5 was shown to be critical for normal germ cell migration during zebrafish 
development(Palamidessi et al. 2008). All these examples indicate that spatial regulation 
and trafficking of signaling molecules, like RAC, is evolutionary conserved to organize 
actin dynamics, polarized protrusion, and directional cell migration, finally affecting the 
mode of motility of normal and cancer cells. 
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2.1.3.5 Migratory and invasive programs are regulated by the trafficking of 
adhesion receptors 
Endocytic trafficking of adhesion receptors directly contributes to invasive 
migration(Ramsay, Marshall, and Hart 2007). Evidence that recycling pathways control the 
capacity of integrin-mediated migration into fibronectin-containing 3D-extracellular matrix 
has been provided that α5β1 associates with RAB25 and is involved in vesicle 
recycling(Caswell et al. 2007). RAB25 sustains the formation of long pseudopodial 
extensions when cells migrate in 3D contexts, and both RAB25 and α5β1 integrin co-
localize in intracellular vesicular compartments within the distal tip of pseudopods(Caswell 
et al. 2007). Moreover, RAB25 promotes spatial restriction confinement of α5β1within the 
tip region of pseudopods cancer cells that move forward through a 3D matrix(Caswell et 
al. 2007). The picture that is emerging from these studies is that there is an intense 
trafficking of vesicles and molecules when cells become motile and that a fine regulation 
of this trafficking is required to ensure a migratory response both in 2D and 3D 
environments.  
2.1.3.6 Endocytosis/recycling controls epithelial cell polarity 
Recent studies have shown that endocytosis and recycling of adhesion molecules are 
essential during developmental processes. For example, the endoytic/recycling route of E-
chaderin, a component of adherent juctions in epithelial cells, is emerging as an important 
mechanism in the assembly and disassembly of epithelial tissues(Yap, Crampton, and 
Hardin 2007). The localization of E-cadherin to adherent junctions is maintained by the 
redirection of the protein to the PM through a recycling pathway instead of preventing its 
endocytosis. The recycling of E-cadherin has been studied in mammalian cells(Paterson et 
al. 2003) and in Drosophila(Langevin et al. 2005), and appears to be controlled by the 
small GTPase RAB11 and by the exocyst complex(Wu et al. 2005). In Drosophila, exocyst 
activity is important for the transportation of E-cadherin from the recycling compartment 
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to the PM(Beronja et al. 2005) or specifically to epithelial cell junctions(Langevin et al. 
2005; Blankenship, Fuller, and Zallen 2007). Thus, the constant turnover of junctional 
material is required for epithelial cells to rapidly adjust polarity and cell-cell contact in 
responce to extracellular cues. 
2.2 NUMB 
2.2.1 NUMB family proteins 
NUMB was originally identified in Drosophila (d-NUMB) as a cell fate 
determinant(Uemura et al. 1989). During ACD of SOP cells in Drosophila, NUMB is 
inherited only by one daughter cell, the pIIb, which acquires a different destiny from the 
pIIa cell(Uemura et al. 1989). In particular, loss of d-NUMB results in defective neuronal 
differentiation, while its ectopic expression causes an increase in neuron differentiation to 
disadvantage of other differentiated cell types(Uemura et al. 1989; Spana and Doe 1996; 
Spana et al. 1995; Rhyu, Jan, and Jan 1994).  
The NUMB protein is conserved throughout the evolution and its mammalian homologues 
are encoded by two genes, numb and numb-like, that were first discovered in mice(Verdi et 
al. 1996; Zhong et al. 1996; Zhong et al. 1997). Both mouse NUMB (m-NUMB) and d-
NUMB show strong sequence similarity with the N-terminal portion of mouse NUMB-
Like (m-NUMB-L) (amino acid 42 to 331), with 76% and 63.7% identity, respectively 
(Fig. 4). The similarity between m-NUMB and m-NUMB-L is present throughout the 
protein, while the similarity between m-NUMB and d-NUMB is restricted to the N-
terminal portion of the protein(Zhong et al. 1997). 
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Figure 4. Schematic representation of m-NUMB-Like, d-NUMB and m-NUMB.  
Amino acid similarity between adjacent proteins is shown as percentage and written between the 
diagrams; homology between m-NUMB-L and m-NUMB is quantified as percentage and is written in 
parentheses. PTB indicates a putative phosphotyrosin binding domain and Q is a poly-glutamine stretch. 
Adopted from(Zhong et al. 1997).  
NUMB functions are conserved between vertebrates and invertebrates and this concept is 
based on two evidences: first, when expressed in Drosophila, m-NUMB shares cellular 
functions with d-NUMB(Zhong et al. 1996; Zhong et al. 1997); second, the chicken 
NUMB homologue is able to antagonize-NOTCH-mediated inhibition of differentiation in 
neuroepithelial cells(Wakamatsu et al. 1999). 
From a structural point of view, NUMB has a modular architecture; it contains an amino 
terminal phosphotyrosin binding (PTB) domain (Bork and Margolis 1995), followed by a 
C-terminal proline reach region (PRR) composed of several putative Src homology (SH3) 
domain-binding sites (Verdi et al. 1996). The PRR region contains two DPF motives that 
are consensus binding sites for the clathrin adaptor α-adaptin, and one NPF motif, which 
associates with proteins containing Eps15 homology (EH) domains (Salcini et al. 1997). 
Both motifs are conserved in all vertebrate NUMB isoforms in the related mammalian 
protein NUMB-Like and in the Drosophila homologue (Salcini et al. 1997). 
The mammalian numb gene encodes for four proteins that derive by alternative splicing of 
two exons: the first exon is located in the PTB domain and the second is located in the 
PRR region(Verdi et al. 1999; Dho et al. 1999). An 11-amino acid (aa) insert in the PTB 
domain (PTBL long) distinguishes NUMB-1 and NUMB-2 from the NUMB-3 and NUMB-
4 (PTBS short). Moreover, the NUMB isoforms 1 and 3 contain an insert of 48 aa in the 
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PRR (also called PRRL long), which is missing in the NUMB isoforms 2 and 4 (PRRS 
short)(Dho et al. 1999; Verdi et al. 1999) (Fig. 5). 
Studies conducted in immortalized mouse neuronal crest cell lines and in primary cultures 
of rat neuronal crest stem cells with overexpressed h-NUMB isoforms showed that PRRS 
containing h-NUMB isoforms promote neuronal differentiation, while the and PRRL h-
NUMB is involved in neuronal proliferation(Verdi et al. 1999). The PTB domain has also 
been reported to control NUMB localization(Dho et al. 1999). The two isoforms containing 
the PTBL are associated with the PM, while the two isoforms containing the PTBS are 
mainly cytoplasmic(Dho et al. 1999). Thus, multiple functions of mammalian NUMB 
could be in part due to the different isoforms and the diversity of interacting proteins(Verdi 
et al. 1996; Verdi et al. 1999; Dho et al. 1999; Karaczyn et al. 2010). 
 
Figure 5. Schematic representation of the four mammalian NUMB isoforms.  
Mammalian Numb gene is transcribed in four different splicing variants, due to the alternate skipping of 
two exons. Arrowheads indicate the boundaries of the protein sequences encoded by the two alternative 
exons. In the upper part, the modular structure of the longest human Numb isoform is shown. The PTB 
domain and the NumbF domain (domain found in the Numb family of proteins adjacent to the PTB 
domain) are indicated. The position of the DPF and NPF motifs are indicated as gray and red boxes 
respectively. In the lower part, a schematic diagram shows the structures of the four Numb isoforms 
which contain either short (S) or long (L) PTB and PRR domains. NUMB 1 and NUMB 2 isoforms are 
associated with PM while NUMB 3 and NUMB 4 isoforms are mainly cytoplasmic. 
Figure modified from (Pece et al. 2011). 
2.2.2 NUMB functions: a biological point of view 
2.2.2.1 Asymmetric cell division 
NUMB owes its name to the fact that its loss of function in Drosophila mutants causes a 
dramatic loss of sensory neurons, causing flies to became “numb”(Pece et al. 2011). 
NUMB appeared in the scientific scene more than twenty years ago when it was shown 
that an intrinsic cellular player participates in cell fate specification during ACD in the 
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fly(Uemura et al. 1989). Indeed, during interphase of SOP, NUMB is equally distributed at 
the PM and is then concentrated at one of the two spindle poles during mitotic division. As 
a consequence of NUMB asymmetric distribution during cytokinesis, the daughter cell that 
inherits NUMB, the pIIb, will have a different destiny from the pIIa cell(Rhyu, Jan, and 
Jan 1994) (Fig 6).  
 
Figure 6. NUMB in ACD of SOP cells of Drosophila.  
The figure describes the ACD in Drosophila SOP. The plane of division with orientation is indicated. 
NUMB is indicated in green as crescent in SOP and as spheres in pIIb cell. For simplicity, only the first 
ACD is represented in detail. However, all the other divisions of pIIb are asymmetric and involve 
asymmetric partitioning of NUMB. 
Modified from(Pece et al. 2011). 
From a molecular point of view, NUMB acts by inhibiting Notch function(Guo, Jan, and 
Jan 1996): the evidence that lead to this conclusion came from experiments performed in 
the SOP system, where gain of function NOTCH mutations phenocopied NUMB loss-of-
function(Guo, Jan, and Jan 1996). Finally, NUMB and NOTCH were shown to directly 
interact(Guo, Jan, and Jan 1996). Of note, the role of NUMB as a cell fate determinant was 
confirmed also in the central nervous system (CNS) in Drosophila(Spana and Doe 1996; 
Spana et al. 1995) and in mammals(Zhong et al. 1996). In particular, NUMB knock-out 
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mice showed severe alterations during the development of the CNS(Zhong et al. 2000), 
linking the NUMB-NOTCH axis to ACD in a true SC compartment.  
Asymmetric NUMB localization and segregation in SOP cells and CNS in Drosophila is 
achieved by the PAR polarity complex machinery, which is evolutionary conserved and 
composed of three proteins: Bazooka (Par3 in mammals)-Par6-aPKC (atypical protein 
kinase C)(Rhyu, Jan, and Jan 1994; Knoblich, Jan, and Jan 1995). In mammals, there are 
direct and indirect evidences suggesting that the PAR polarity complex controls NUMB 
asymmetrical distribution during ACD: mammalian NUMB binds to aPKC and 
Par3(Nishimura and Kaibuchi 2007; Wang et al. 2009) and is phosphorylated by 
aPKC(Nishimura and Kaibuchi 2007; Smith et al. 2007). NUMB asymmetric cellular 
distribution may promote distinct fates in stem/progenitor cells by interacting with 
components of signaling pathways triggered by specific micro environmental cues(Pece et 
al. 2011). The identity and function of the micro-environmental key factors that crosstalk 
with NUMB to trigger the cell fate choice are not fully understood as yet. Nevertheless, a 
number of pathways that control stem/progenitor cell development have been described to 
interact with NUMB. For instance, NOTCH or Hedgehog (Hh) activation and loss-of-
function of p53 promote SC maintenance and expansion. 
2.2.2.2 Endocytosis 
The molecular mechanisms by which NUMB functions remained unveiled for a long time. 
Initially, hypotheses and interpretation of data describing NUMB-NOTCH antagonism 
focused mainly on the NOTCH signaling pathway(Guo, Jan, and Jan 1996).  Later, it 
became increasingly clear that NUMB is expressed in almost all cells, and in the vast 
majority of these, cell division and the subsequent NUMB segregation at mitosis is 
symmetric. In some settings, however, the asymmetric distribution of NUMB, and 
consequently cell fate specification, leads to biochemical asymmetry, suggesting that 
NUMB is involved in the regulation of basic cellular functions.  
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The first data that showed how NUMB could work derived from the study of protein-
protein interaction in the endocytic network(Salcini et al. 1997; Di Fiore, Pelicci, and 
Sorkin 1997; Paoluzi et al. 1998; Santolini et al. 1999), in which h-NUMB was found to 
interact with the EH domain of two endocytic proteins, epidermal growth factor substrate 
15 (EPS15) and epidermal growth factor substrate 15-like 1 (EPS15L1)(Coda et al. 1998; 
Confalonieri et al. 2000; Fazioli et al. 1993), suggesting a putative role for NUMB in 
endocytosis(Salcini et al. 1997; Confalonieri and Di Fiore 2002). Subsequentially, NUMB 
was defined as an endocytic protein(Santolini et al. 2000) based on its subcellular 
localization in endocytic organelles, its co-trafficking with internalizing receptors, its 
interaction with the α-adaptin subunit of the major clathrin adaptor AP2, and the ability of 
dominant negative NUMB mutants to block constitutive and ligand-induced 
endocytosis(Santolini et al. 2000). In the following years, a number of studies established 
the involvement of NUMB in internalization and recycling, consolidating the role of 
NUMB in endocytosis.  
2.2.2.3 Internalization  
The first link between NUMB and internalization could be directly coupled to NUMB 
function as a cell-fate determinant in the SOP system (Berdnik et al. 2002). In a genetic 
screen for mutations affecting bristle morphology in the fly, it was found that α-adaptin 
phenocopies loss-of-function NUMB mutants(Berdnik et al. 2002). Of note, all isolated α-
adaptin mutants are characterized by a mutation in the ear domain, the very same domain 
with which NUMB interacts. Genetic analysis showed that, in the SOP linage, α-adaptin 
acts downstream of NUMB and upstream of NOTCH. α-adaptin partitions asymmetrically 
in pIIb cells through a NUMB-dependent manner(Berdnik et al. 2002). These results show 
that the NUMB-α-adaptin axis couples endocytosis with cell-fate specification and further 
suggest that the mechanism of NUMB-NOTCH counteraction could be due to unequal 
NOTCH endocytosis in the pIIb cell vs. the pIIa cell, resulting in biochemical and 
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signaling asymmetry. Subsequent work in Drosophila and mammals reinforced the 
concept that NUMB plays a role in the internalization step of endocytosis (Fig. 7). 
 
 
Figure 7. NUMB functions in endocytosis and recycling.  
The figure describes NUMB functions in the intracellular trafficking. Cellular activities controlled by 
the endocytic functions of Numb (migration, adhesion, metabolism, proliferation/differentiation) are 
indicated in red. Violet, red and green arrows indicate internalization, degradative and recycling routes, 
respectively. ECM, extracellular matrix; LDLR, low-density lipoprotein receptor; FAs, focal adhesions; 
AJs, adherens junctions. 
Modified from(Pece et al. 2011). 
In the SOP system, NUMB was shown to be necessary for the endocytosis of Sanpodo, a 
membrane protein required for NOTCH signaling(Hutterer and Knoblich 2005; Roegiers, 
Jan, and Jan 2005). In mammals, NUMB was found to regulate endocytosis of the neuronal 
cell adhesion molecules L1(Nishimura et al. 2003), integrin ß-1 and integrin ß3(Nishimura 
and Kaibuchi 2007). In another study, NUMB removal increased the surface levels of α1, 
α5 and ß1 integrins, a result compatible with the role of NUMB in their 
endocytosis(Teckchandani et al. 2009).   
The role of NUMB as a cargo-selective adaptor is conflicting. Teckchandani and 
colleagues showed that NUMB is not required for the internalization of the 
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TfR(Teckchandani et al. 2009), while Sorensen and colleagues published that NUMB is 
involved in TfR internalization upon phosphorylation by a key endocytic kinase, adaptor-
associate kinase 1 (AAK1)(Sorensen and Conner 2008). The expression of a NUMB 
mutated in the phosphorylation site from AAK1 impairs the uptake of TfR and LDLR but 
not that of EGFR(Sorensen and Conner 2008), reminding of the principle of cargo 
selectivity. Although some differences could be due to the experimental settings, NUMB 
may be seen as a cargo-selective adaptor. In fact, NUMB is structurally related to cargo-
selective endocytic adaptors, such as Disabled-2 (DAB-2) and the autosomal recessive 
hypercholesterolemia protein (ARH). In particular, the PTB domains of these protein are 
highly related and share some features, like the ability to bind to acid phosphoinositides 
that mediated the interaction with the PM(Dho et al. 1999; Mishra et al. 2002; Mishra, 
Watkins, and Traub 2002). Both DAB2 and ARH are cargo-selective adaptors(Mishra et 
al. 2002; Mishra, Watkins, and Traub 2002; Teckchandani et al. 2009), supporting the idea 
that NUMB may belong to the same functional family of endocytic adaptors.  
2.2.2.4 Recycling 
The idea that NUMB is more than an adaptor protein in the internalization step came from 
studies conducted in Dr. Jane McGlade’s laboratory (Fig. 7). They found that NUMB 
interacts and co-localizes in vivo with the EHD (EH-domain) protein family, which 
function in recycling of PM receptors internalized both by CME and NCME regulated by 
ARF6. Moreover, both NUMB and EHD proteins were found to be localized in vesicles 
containing the small GTPase ARF6, which represent the recycling endosomes(Smith et al. 
2004). Genetic analysis in the nematode C. Elegans proved the role of NUMB in recycling. 
In this system, overexpression of NUM-1A (the nematode NUMB homolog) phenocopies 
the loss of function of rme-1, the nematode homolog of EHD(Nilsson et al. 2008). These 
results indicated that NUM-1A negatively regulates recycling, a finding consistent with the 
fact that loss of NUM-1A bypasses the requirement for RME(Nilsson et al. 2008).  Later 
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on, the same group further characterized the molecular mechanism and proposed that 
NUM-1A inhibits recycling by preventing the ability of TAT-1 to translocate 
phosphatidylserine synthetize in the recycling endosome(Nilsson, Jonsson, and Tuck 
2011). The role of NUMB as a negative regulator of recycling could also be extended to 
mammals. In C2C12 myoblastic cells, overexpression of NUMB promotes sorting of 
NOTCH through the late endosomes for degradation, while its depletion promotes NOTCH 
recycling(McGill et al. 2009). In the last few years, a role for NUMB as a negative 
regulator of recycling has emerged, and the molecular mechanisms through which NUMB 
affects recycling are only now being addressed. Recently, two complementary works 
described a “recycling inhibition model” in which NUMB negatively regulates the 
recycling of Sanpodo in the Drosophila SOP system(Couturier, Mazouni, and Schweisguth 
2013; Cotton, Benhra, and Le Borgne 2013). Collectively, they showed that Sanpodo is a 
positive regulator of NOTCH turnover and that NUMB inhibits the recycling of 
internalized NOTCH-Sanpodo via its interaction with Sanpodo in sorting 
endosome(Cotton, Benhra, and Le Borgne 2013; Couturier, Mazouni, and Schweisguth 
2013). The authors proposed that the AP-2- and AP-1-dependent trafficking, regulated by 
NUMB, is required for Sanpodo localization(Cotton, Benhra, and Le Borgne 2013; 
Couturier, Mazouni, and Schweisguth 2013). Although the molecular mechanism is still 
not clear, this scenario is in line with the proposed role for NUMB in C. Elegans(Nilsson et 
al. 2008) and in mammals(McGill et al. 2009). The recycling inhibition model can be 
applied also to fish, where it has been shown that the OPO protein (a transmembrane 
protein similar to Sanpodo) interacts with NUMB via a conserved NPAF motif and 
antagonizes NUMB in the control of integrin trafficking(Bogdanovic et al. 2012). 
2.2.2.5 Cell adhesion, migration and epithelial-mesenchymal transition 
Given its role in endosomal trafficking of transmembrane receptors, NUMB could be 
involved in the control of cells adhesion. Indeed, NUMB has been reported to localize in 
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RAB11-positive recycling endosomes containing cadherin. NUMB interacts via its PTB 
domain and C-terminal(Rasin et al. 2007) domain with the cadherin-catenin complex, 
which in other words is the association of E-cadherins, alpha cathenins and beta-catenins 
with the actin cytoskeleton. The cadherin/cathenin complex regulates PM dynamics, cell 
migration and cell shape(Pollard and Borisy 2003). Continuous internalization of cadherins 
and recycling to and from the cell surface via the endocytic machinery is necessary for the 
maintenance of adherence junctions(Nishimura and Kaibuchi 2007; Rasin et al. 2007).  
Moreover, cadherins and integrins have been identified as binding partners for 
NUMB(Casanova 2007a). In fact, NUMB binds to integrin-ßs(Nishimura and Kaibuchi 
2007), leading to integrin endocytosis and directional cell migration towards integrin 
substrates. NUMB is also involved in the directional integrin trafficking in migrating cells, 
in which NUMB localizes in clathrin-containing structures at the leading edge and around 
focal adhesions(Nishimura and Kaibuchi 2007). Depletion of NUMB induces a decrease in 
endocytosis and in integrin-stimulated cell migration(Nishimura and Kaibuchi 2007). 
NUMB is also required for epithelial polarity and cell-cell adhesion in epithelial-
mesenchymal transition (EMT). The EMT is a critical process in development and plays an 
important role in many physiological processes. In addition, cancer cells can re-activate 
EMT in order to execute migratory programs associated with metastasis(Thiery and 
Sleeman 2006). In epithelial cells, under physiological condition, NUMB binds to E-
cadherin or to the PAR complex via PAR3(Wang et al. 2009). Removal of NUMB in 
Mandin Darby Canine (MDCK) cells leads to lateral mislocalization of PAR3 and a-PKC, 
a decrease in cell adhesion, apical translocation of E-cadherin and ß-catenin, an increase in 
cell migration and proliferation, and to active F-actin polymerization. These data suggest 
that NUMB plays a role in the regulation of cell polarity, cell adhesion and cell migration 
during EMT. 
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2.2.3 NUMB regulates different signaling pathways 
2.2.3.1 The NOTCH pathway 
NUMB was originally identified as an inhibitor of NOTCH signaling in 
Drosophila(Uemura et al. 1989; Skeath and Doe 1998). NOTCH is activated by 
engagement with ligands of the DLS protein family (Fig.8). Upon binding to its ligands, 
NOTCH undergoes a series of proteolytic cleavages. As a consequence, the NOTCH 
intracellular domain (NICD) is translocated from the cytosol to the nucleus, where it 
converts CSL proteins (CFB1, RBPjk, Suppressor of Hairless, Lag1) from transcriptional 
repressors to transcriptional activators, thereby turning on the expression of target 
genes(De Strooper et al. 1999; Jarriault et al. 1995; Mumm et al. 2000; Struhl and 
Greenwald 1999).  
 
Figure 8. Notch signaling pathway.  
The figure describes the NOTCH signaling pathway. The signaling sending cell express the NOTCH 
ligand on its surface. The ligand binds to the receptor, expressed by the signaling receiving cell and the 
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receptor undergoes to a series of proteolytic cleavages releasing the NICD. Then the NICD enters into 
the nucleus where it activates transcription. NECD: NOTCH extracellular domain; NICD: NOTCH 
intracellular domain; NEXT: NOTCH extracellular truncated domain; CSL: CBF1/Suppressor of 
Hairless/LAG-1; MAML: Mastermind/Lag-3; Co-A: co-activators; Co-R: co-repressors; Nβ: short 
peptide released after cleavage at site 4. 
Modified from (Yavropoulou and Yovos 2014)  
 
One theory of how NUMB regulates NOTCH is that NUMB acts as an adaptor between 
NOTCH and its E3-ubiquitin ligase Itch(Qiu et al. 2000), causing poly-ubiquitination  and 
degradation of cytoplasmic NICD but not of the membrane bound form of NOTCH(McGill 
and McGlade 2003). NUMB has been shown to interact with Itch in the same region in 
witch NOTCH binds Itch, and co-expression of NUMB and Itch further enhances the 
ubiquitination of the NICD(McGill and McGlade 2003). In addition, to facilitating 
NOTCH ubiquitination, NUMB controls the intracellular trafficking of NOTCH, thereby 
suppressing its function (see section 2.2.4). These data indicate that, in mammals, NUMB 
regulates post-endocytic sorting of NOTCH, leading to its degradation(McGill et al. 2009).  
2.2.3.2 The Hedgehog pathway 
Another pathway that is regulated by NUMB is the Hedgehog (Hh) signaling pathway(Di 
Marcotullio et al. 2006). The Hh signaling pathway is fundamental during development of 
multicellular organisms, including humans(Teglund and Toftgard 2010; Varjosalo and 
Taipale 2008).  Initially, Hh was discovered as a “segment-polarity” gene that controls 
Drosophila embryonic cuticle pattern(Nusslein-Volhard and Wieschaus 1980). Hh is a 
secreted molecule and is subject to an autocatalytic cleavage, resulting in an N-terminal 
activated fragment(Porter et al. 1995), which is modified by the addition of a cholesterol 
moiety at the C-terminus(Porter et al. 1996). Only one Hh gene is present in the fly. In 
vertebrates, instead, three homologues have been described: Sonic (Shh), Desert (Dhh) and 
Indian (Ihh)(Echelard et al. 1993; Marigo et al. 1996; Stone et al. 1996), and all three are 
responsible for the activation of the pathway upon binding to their related receptor, 
Patched. The most widely studied vertebrate Hh gene is Shh, which is expressed 
throughout the developing CNS, lungs, limbs, gut, hair follicles, and teeth(Bellusci et al. 
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1997; Goodrich et al. 1996; St-Jacques et al. 1998).  The pathway terminates with the 
activation of three transcription factors; Gli1, Gli2 and Gli3(Dai et al. 1999; Sasaki et al. 
1999). Besides tissue development, the Hg pathway has been implicated in numerous 
cellular processes ranging from cell proliferation and differentiation, to migration, and to 
DNA repair. It is also involved in tissue repair/regeneration and in SC self-
renewal(Varjosalo and Taipale 2008; Teglund and Toftgard 2010; Jiang and Hui 2008).  
Alteration of the Hg pathway have been implicated in a variety of developmental 
abnormalities and in different types of cancer(Jiang and Hui 2008; Teglund and Toftgard 
2010; Varjosalo and Taipale 2008; Mullor, Sanchez, and Ruiz i Altaba 2002).  
Studies conducted in mouse cerebellar granule cell progenitors (GCPs) have shown that Hh 
expression maintains GCPs proliferating and undifferentiated, while its inhibition leads to 
GCPs differentiation(Di Marcotullio et al. 2006). Importantly, this transition correlates 
with the expression of NUMB in developing GCPs and to the association of NUMB with 
Gli1 and the recruitment of the E3-ubiquitin ligase Itch, causing, thus, Gli1 proteasome-
dependent degradation(Di Marcotullio et al. 2006). As a consequence, Hg signaling is 
suppressed and GCPs begin to differentiate(Di Marcotullio et al. 2006).  
2.2.3.3 The p53 pathway 
A recent work from our group has described a new role for NUMB in the regulation of the 
tumor suppressor protein TP53  (p53)(Colaluca et al. 2008). p53 is a transcription factor 
that activates different downstream genes(Farmer et al. 1992) and their related pathways, 
such as apoptosis(Shaw et al. 1992), DNA repair , growth arrest(Yonish-Rouach et al. 
1991), and cell cycle arrest(el-Deiry et al. 1992). p53 protein levels and its activity are 
regulated by different stress-induced signaling, like DNA damage or UV radiation(Kastan 
et al. 1991; Maltzman and Czyzyk 1984), preventing thus genome instability and 
tumorigenesis(Vogelstein, Lane, and Levine 2000; Lane 1992). p53 is a tumor suppressor 
in cancer because 50% of all human cancers have been show to contain mutations in both 
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alleles of the p53 gene. Many tumors express high levels of p53 but in tumors in which p53 
is mutated, its function is lost despite the high expression levels(Bartek, Bartkova, et al. 
1990; Bartek, Iggo, et al. 1990; Iggo et al. 1990). One mechanism of p53 inactivation 
occurs through the activation of the oncogene E3 ubiquitin ligase Mouse double minute 2 
(MDM2; HDM2 in human), which is responsible for p53 ubiquitination and subsequent 
proteasomal degradation(Haupt et al. 1997; Kubbutat, Jones, and Vousden 1997). MDM2 
expression is a transcriptional target of p53, which causes increased MDM2 levels but 
lower p53 levels(Wu et al. 1993). NUMB binds and blocks MDM2, preventing the 
ubiquitination and degradation of p53 in the normal mammary epithelial cell line, 
MCF10A(Colaluca et al. 2008). Notably, the downregulation function of NUMB over 
MDM2 occurs in the contest of NUMB/p53/MDM2 tri-complex(Colaluca et al. 2008), 
which results in increased p53 levels and activity, and p53-dependent phenotypes. On the 
contrary, NUMB removal decreases p53 levels and activity, and is accompanied by DNA-
damage, deregulated apoptosis, and cell cycle checkpoint activation response(Colaluca et 
al. 2008).  
2.2.3.4 The TCTP pathway 
Translationally controlled tumor protein (TCTP) was initially identified as a factor 
implicated in cell growth(Thomas, Thomas, and Luther 1981; Yenofsky, Bergmann, and 
Brawerman 1982). TCTP is ubiquitously expressed, suggesting an important role for this 
protein in normal physiological function(Chen SH1 2007). This protein also plays a role in 
a number of cellular events related to cancer progression(Cans et al. 2003; Jung et al. 2004; 
Yoon et al. 2000; Liu, Urbe, and Clague 2012) and is directly involved in malignant 
transformation(Tuynder et al. 2004; Tuynder et al. 2002; Arcuri et al. 2004). In line with 
these functions, TCTP-dependent transformation has been coupled to TCTP regulation of 
p53 and vice versa. As described above, NUMB enters in a complex with p53 and prevents 
p53 degradation(Colaluca et al. 2008); in this contest, TCTP competes with NUMB for 
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MDM2 binding, promoting p53 ubiquitination and degradation(Amson et al. 2012). In 
addition, TCTP increases the MDM2-mediated ubiquitination of p53(Amson et al. 2012). 
2.2.4 Deregulation of NUMB and cancer 
2.2.4.1 NUMB acts as a tumor suppressor in human cancers 
Considering its critical role in many cellular processes, subversion of NUMB has been 
linked to important human pathologies(Pece et al. 2010), including 
neurodegeneration(Kyriazis et al. 2008; Merdes et al. 2004; Roncarati et al. 2002) and 
cancer(Pece et al. 2004; Wang et al. 2015; Westhoff et al. 2009; Wu et al. 2014; Xie et al. 
2015). Initial evidences that highlighted NUMB as a potential tumor suppressor came from 
Drosophila(Rhyu, Jan, and Jan 1994; Guo, Jan, and Jan 1996; Wang et al. 2009), where it 
was described as a negative regulator of NOTCH signaling through its direct interaction 
with NOTCH via its PTB(Guo, Jan, and Jan 1996; Rhyu, Jan, and Jan 1994). Remarkably, 
NUMB was also identified as a tumor suppressor in an in vivo RNA screening in a mouse 
model of lymphomagenesis, whose loss can accelerate the onset of lymphomas(Bric et al. 
2009). 
Loss of NUMB occurs in 50% of all breast cancers(Pece et al. 2004) and correlates with 
poor prognosis(Colaluca et al. 2008), a less-differentiated phenotype, compered to NUMB 
expressing tumors(Colaluca et al. 2008; Pece et al. 2004; Rennstam et al. 2010), and the 
expression of cancer stem cell (CSC) markers(Rennstam et al. 2010); this latter is 
interesting as recent findings show that poorly differentiated breast tumors harbor a higher 
CSC-content than well-differentiated tumors(Pece et al. 2010). Loss of NUMB in breast 
tumors leads to the alteration of two distinct pathways: the hyper-activation of the 
NOTCH-driven oncogenic pathway and the downregulation of the p-53-induced tumor 
suppressor pathway(Colaluca et al. 2008; Pece et al. 2004), thus, inducing tumor 
transformation(Colaluca et al. 2008; Pece et al. 2004). These evidences directly correlate 
with human breast cancer. Indeed, the ectopic re-expression of NUMB in NUMB deficient 
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(but not NUMB-proficient) tumors inhibits proliferation and reverts NOTCH signaling to 
basal levels (Pece et al. 2004). Moreover, restoration of NUMB levels in human primary 
breast tumors cells rescues p53 expression and sensitizes cells to chemotherapeutic 
treatment, while NUMB ablation in NUMB-proficient tumor cells confers 
chemoresistance(Colaluca et al. 2008).  
The expression of NUMB is lost in about 30% of all non-small cell lung carcinomas 
(NSCLCs)(Westhoff et al. 2009), with concomitant activation of the NOTCH pathway and 
addiction to high NOTCH levels. In 10% of these tumors, gain-of-function mutations in 
the NOTCH gene lead to NOTCH activation in a NUMB-independent manner and 
correlates with a poor clinical outcome in NSCLC patients that do not present p53 
mutations(Westhoff et al. 2009). In both breast cancer and NSCLCs, loss of NUMB is due 
to a massive ubiquitination and degradation; in fact, NUMB protein levels can be restored 
by proteasomal inhibition and the restoration event is coupled with hyper-ubiquitination in 
NUMB-deficient, but not NUMB-proficient, tumors(Pece et al. 2004; Westhoff et al. 
2009).  Loss of NUMB occurs in the absence of genetic lesions to the NUMB locus and in 
the presence of normal RNA levels(Pece et al. 2004; Westhoff et al. 2009). It is possible 
that NUMB alterations are caused by the components of the 
ubiquitination/deubiquitination system. 
Reduced NUMB levels also correlate with poor prognosis in salivary gland 
carcinoma(Maiorano et al. 2007), in clear cell renal cell carcinoma (ccRCC)(Sima et al. 
2015) and in hepatocellular carcinoma(Sima et al. 2015; Xie et al. 2015), although no 
additional mechanisms are currently known for these tumors. 
2.2.4.2 NUMB controls stem cell fate and differentiation in cancer 
The tumor suppressor role of NUMB in cancer could be related to its ability to control 
stem/progenitor fate.  It has been known for many years that only a small portion of human 
tumor cells can give rise to tumors when transplanted in immunocompromised 
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mice(Gupta, Vyas, and Enver 2009; Reya et al. 2001). These cells are defined as cancer 
stem cells (CSCs) and it is hypothesized that only these are capable of self-renewal. 
Therefore, it is understandable that NUMB is the target of transformation in the stem cell 
compartment. Indeed, our group has demonstrated that in the mammary gland 
compartment NUMB plays a dual role(Tosoni et al. 2015). In the stem cell (SC) 
compartment, NUMB establishes an asymmetric mode of division and is retained in the 
cell that maintains the SC identity by sustaining high p53 activity.  At progenitor level, loss 
of NUMB correlates with EMT and results in differentiation defects and reacquisition of 
stemness features (Tosoni et al. 2015). NUMB removal in the mouse mammary gland 
results in an expansion of the SC compartment, morphological alteration and 
tumorigenicity due to low p53 levels(Tosoni et al. 2015). These latter phenotypes could be 
rescued by restoration of p53 levels or activity, which could be a potential SC-targeted 
treatment(Tosoni et al. 2015).  
2.2.4.3 How NUMB acts in cancer: the circuitry level 
From a biochemical and molecular point of view, the tumor suppressor function of NUMB 
are connected with growth promoting and growth suppressing circuitries (Fig. 9). For 
example, in the absence of NUMB, both NOTCH and Hh signaling are increased and result 
in pro-proliferative and anti-differentiative effects, while the signaling of the tumor 
suppressor p53 is attenuated. Moreover, subversion of NUMB is predicted to have a major 
impact on the entire homeostasis of endocytosis, itself proposed as a tumor suppressor 
mechanism(Lanzetti and Di Fiore 2008; Polo, Pece, and Di Fiore 2004).  
Lastly, the alteration of many polarity function, connected with the PAR polarity 
complex(Aranda, Nolan, and Muthuswamy 2008; Goldstein and Macara 2007; Sancho, 
Batlle, and Clevers 2004), could contribute to transformation events, such as deregulation 
of PAR complex activity as a key factor for initiation of transformation(Wang et al. 2009), 
established or sustained by loss-of-NUMB. In this scenario, the implication of NUMB in 
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the control of EMT is interesting: loss of NUMB causes phenotypes characteristic of EMT, 
which is a strategy used by tumor cells to acquire invasive ability and resistance to cell 
death, senescence, immunosurveillance, immunotherapy and chemotherapy(Singh and 
Settleman 2010; Thiery et al. 2009), thereby confirming the involvement of NUMB in 
tumor-related phenotypes. 
Figure 9. NUMB in cancer. 
The figures describe a “hypothetical division” of mammalian SC, in which NUMB segregates only in 
one daughter cell. The pathways that would be inherited in the daughter cell that receives NUMB (left), 
and in the daughter cell that does not receive it (right), are depicted. The figure also shows a simplified 
view of the difference between a normal cell and a cancer cell, in which the expression of NUMB is 
lost. 
Modified from(Pece et al. 2011). 
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2.3 ARF proteins 
The ARF protein family belongs to the Ras Superfamily of small GTPases(D'Souza-
Schorey and Chavrier 2006; Donaldson and Jackson 2011a). The ARFs have been shown 
to participate in many cellular processes, like control of membrane trafficking, activation 
of enzymes and regulation of actin remodeling(D'Souza-Schorey and Chavrier 2006; 
Donaldson and Jackson 2011a). The mammalian ARF protein family is composed of 6 
members that are grouped in three classes based on sequences homology: Class I (ARF1, 
ARF2, ARF3), Class II (ARF4 and ARF5) and Class III (ARF6)(D'Souza-Schorey and 
Chavrier 2006; Donaldson and Jackson 2011a). While the function of class II ARF proteins 
is still unclear(D'Souza-Schorey and Chavrier 2006), Class I ARF proteins have been 
shown to regulate the assembly of different types of coated complexes in the secretory 
pathway(Bonifacino and Glick 2004) and ARF6, the only member of Class III, controls 
mainly the endosomal membrane trafficking and the structural organization at the cell 
surface(D'Souza-Schorey et al. 1995; Peters et al. 1995). Like others small GTPases of the 
Ras Superfamily, ARF proteins cycle between an active GTP-bound status and an inactive 
GDP bound status(D'Souza-Schorey and Chavrier 2006; Donaldson and Jackson 2011a). 
The on-off status is controlled by guanine nucleotide exchange factors (GEFs) and 
GTPase-activating proteins (GAPs), which are activators and inactivators, respectively 
(Fig. 10). GAPs catalyze the hydrolysis of bound GTP and are important because ARFs 
have low intrinsic GTP-hydrolysis activity. GEFs, through a conserved SEC7 domain, 
catalyze the release of GDP from the ARF substrate (Fig. 11)(D'Souza-Schorey and 
Chavrier 2006; Donaldson and Jackson 2011a). All ARF proteins are anchored to the PM 
by myristoylation, lipid modification, at the second Gly residue of the N-terminus(Amor et 
al. 1994).   
The functions of the ARFs are mainly dependent on the unique cellular distribution of each 
ARF and on their binding partners. So far, crystallography studies reveled that while the 
switch regions of ARF1 and ARF6 assumes different conformations in the GDP-bound 
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state, the GTP bound structures are very similar(Pasqualato et al. 2001). This raises the 
issue of the specificity of downstream interactors and protein functions of activated ARF. 
Indeed, the majority of ARF effector molecules that have been identified can interact with 
more than one ARF protein in vitro(Shin, Couvillon, and Exton 2001; Shin and Exton 
2001; Kawasaki, Nakayama, and Wakatsuki 2005; Brown et al. 1993; Cockcroft et al. 
1994). However, in cells, ARF proteins have different localization, which allows each 
member of the family to perform a specific function(Peters et al. 1995). Probably, different 
interactors and effectors establish a specific interaction with active ARF outside the switch 
region(Al-Awar et al. 2000). 
 
Figure 10. The GDP/GTP cycle of ARF protein. 
The ARF family of G proteins undergoes a cycle of GTP binding and hydrolysis of GEFs and GAPs, 
respectively. The GTP-bound form acts through interaction with ‘classical effectors’, including vesicle 
coat proteins and enzymes that can change membrane lipid composition. GDP-specific effectors are less 
known. 
Modified from(Donaldson and Jackson 2011a).  
Although ARF1 and ARF6 have unique cellular localization, it is now emerging that ARF6 
plays a role at the cell surface, similar to the one of ARF1 at the Golgi apparatus, in which 
ARF1 controls the assembly of clathrin and non-clathrin coats and organelle 
structure(D'Souza-Schorey and Chavrier 2006).  
As the aim of this PhD project was to functionally characterize the relationship between 
NUMB, ARF6 and its GEFs EFA6B, I will now give a brief description of ARF6 function 
in endosomal recycling and actin remodeling, followed by a description of its GEFs and 
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their function, with a special focus on the EFA6 family.  
2.3.1 ARF6 
ARF6 is the least-conserved member of the ARF protein family(D'Souza-Schorey and 
Chavrier 2006). It localize to the PM and to the endosomal compartment, where it 
regulates endocytic membrane trafficking and actin remodeling(D'Souza-Schorey and 
Chavrier 2006). The GTP-GDP cycles facilitate ligand internalization and trafficking along 
the endocytic pathway upon internalization, endosomal recycling and the fusion of an 
endosomal membrane with the PM(Schweitzer, Sedgwick, and D'Souza-Schorey 2011). 
On the cell surface, ARF6 facilitates receptor internalization and its activation is required 
for membrane recycling back to the cell surface(Schweitzer, Sedgwick, and D'Souza-
Schorey 2011).  
ARF6 regulates the entry of cargos, either via CME or NCME, by changing the lipid 
composition of the PM (Fig. 11). Indeed, ARF6-GTP activates phosphatidylinositol-4-
phosphate-5-kinase (PIP5K)(Honda et al. 1999; Krauss et al. 2003) and phospholipase D 
(PLD)(Brown et al. 1993; Cockcroft et al. 1994), which results in the production of 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and phosphatidic acid (PD). In the 
presence of these lipids, active ARF6 recruits NM23-H1(Palacios et al. 2002) and the 
clathrin adaptor AP2(Krauss et al. 2003) to promote CME. ARF6 is also able to interact 
with arrestins to facilitate GPCRs internalization(Claing et al. 2001) and with AP2(Paleotti 
et al. 2005) and clathrin during GPCR-mediated cell signaling(Poupart et al. 2007) (Fig. 
11). A recent work has demonstrated that ARF6 is internalized in clathrin-coated vesicle to 
facilitate the fast recycling route of the TfR back to the PM through interaction with the 
microtubule motor adaptor protein JNK-interacting protein 4 (JIP4) after clathrin 
uncoating(Montagnac et al. 2011). ARF6 promotes also internalization via NCME and 
caveolae(Donaldson 2003). Ligands that are internalized via this pathway include the 
major histocompatibility complex class I protein (MHC class I), M2 acetylcholine 
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receptors, ß1 integrins and the peripheral myelin-membrane protein (PMP22)(Donaldson 
2003).  
As discussed above, upon internalization either via CME or via NCME, macromolecules 
reach the EE(Maxfield and McGraw 2004). For example, internalized ß1 integrin in HeLa 
cells is recycled to the cell surface in an ARF6-dependent manner and co-localizes with 
internalized TfR, the small GTP-binding protein Rab11, and MHC class I molecules in 
recycling endosome(Powelka et al. 2004). 
The first evidence that ARF6 is required for endosomal recycling derived from 
experiments in Chinese Hamster Ovary (CHO) cells in which the expression of dominant 
negative ARF6 mutants blocked the recycling of endosomal ligands(D'Souza-Schorey et 
al. 1995; Stearns et al. 1990). Recycling to the PM may occur directly from the EE or 
through a pericentriolar-recycling endosomal compartment(Maxfield and McGraw 2004). 
Experiments in HeLa cells showed that ARF6 activity affects the recycling of integral PM 
proteins that lack cytoplasmic AP2 and a clathrin sorting sequence, including the IL-2 
receptor α-subunit, the MHC class I and the glycosylphosphatidylinositol (GPI)-anchored 
protein(Naslavsky, Weigert, and Donaldson 2003; Radhakrishna and Donaldson 1997). 
ARF6-positive tubules in these cells slightly overlap with EEs and diffuse from the 
perinuclear region to the cell periphery.  
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Figure 11.  ARF6 regulates the CME and the NCME pathways. 
ARF6-GTP mediates its effects on CME and NCME through PIP5K and PLD, and through the 
production of PI(4,5)P2. ARF6-regulated recruitment of NM23-H1 and/or the adaptor protein AP-2 
facilitates CME ARF6 activation is also required for the dissociation of arrestin molecules to facilitate 
receptor internalization. ARF6–GTP hydrolysis through specific GAPs is required for further trafficking 
along each pathway, whereas the activation of ARF6 through specific GEFs promotes the recycling and 
subsequent fusion of an endosomal membrane with the PM. ARF6-regulated membrane recycling is 
dependent in part on the vesicle-tethering exocyst complex and PLD. 
Modified from(D'Souza-Schorey and Chavrier 2006). 
In addition to its role in endosomal membrane trafficking, ARF6 is required for actin 
remodeling at the cell periphery and for events that require a rapid change in cell-surface 
shape(D'Souza-Schorey and Chavrier 2006). ARF6-dependent actin remodeling is 
necessary for the formation of pseudopods and membrane ruffles(D'Souza-Schorey et al. 
1997; Radhakrishna, Klausner, and Donaldson 1996), neuritis outgrowth and cell 
spreading(Albertinazzi et al. 2003; Hernandez-Deviez et al. 2004), cell migration(Palacios 
et al. 2001; Riley et al. 2003; Santy and Casanova 2001) and phagocytosis(Balana et al. 
2005; Niedergang et al. 2003; Wong and Isberg 2003; Zhang et al. 1998). ARF6 activity 
induces alteration in the actin cytoskeleton by its influence on RAC1, RAC1 effectors and 
phospholipid modulation(D'Souza-Schorey and Chavrier 2006). It has been proved that 
ARF6 facilitates the re-localization of endosomes containing RAC1 to the cell 
surface(Radhakrishna et al. 1999; Boshans et al. 2000). Moreover, ARF6 can induce the 
trafficking of RAC1 to the PM and regulate the activation of RAC1 via its activation of 
ERK, thereby impacting on RAC-mediated rearrangement of the actin cytoskeleton(Tushir 
and D'Souza-Schorey 2007). The migratory ability of cells is also modulated by the 
integrin engagement with the extracellular matrix and requires ARF6-mediated activation 
of RAC1 for the formation of migratory structures(Schweitzer, Sedgwick, and D'Souza-
Schorey 2011).  
Since ARF6 plays numerous roles in remodeling of the actin cytoskeleton, it is not 
unexpected that its activity affects several cellular events that require a rapid change in cell 
surface morphology. For example, ARF6 has been reported to be an important factor in the 
regulation of cell-cell(D'Souza-Schorey 2005) and cell- extracellular matrix (ECM) 
adhesion. In epithelial cells, activated ARF6 favors the internalization of E-cadherin from 
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cell-cell contact sites to EEs, which causes the disruption of adherens junctions. On the 
contrary, the expression of a dominant-negative ARF6 mutant blocks HGF-induced 
internalization of E-cadherin(D'Souza-Schorey 2005). ARF6 is also involved in the control 
of adhesion to the ECM by acting directly on the distribution of ß1 integrin 
receptors(D'Souza-Schorey 2005). ARF6 has also been shown to be involved in the 
regulation of syndecan recycling, a heparan sulfate proteoglycan ECM molecule, by 
interacting with syntenin, a PDZ domain-containing adaptors, and PI(4,5)P2, on recycling 
endosomes(Zimmermann et al. 2005).  
Invadopodia are actin-rich structures that are required for the degradation of the 
ECM(Buccione, Orth, and McNiven 2004). In vitro cell invasion assays, using breast 
cancer and melanoma cell lines, have demonstrated that the removal of ARF6 or the 
expression of its dominant negative mutant inhibits cell invasion, proving, thus, that ARF6 
activity can impinge on the invasive potential of tumor cells(Hashimoto et al. 2004; Tague, 
Muralidharan, and D'Souza-Schorey 2004). 
All examples described until now point to the fact that the ARF6-dependent endosomal 
trafficking impinges on different cellular activities like cell migration, disassembly of cell-
cell contact, change in cell shape, and degradation of ECM. Finally, other cellular 
functions regulated by ARF6-mediated endosomal trafficking are cytokinesis, by 
promoting the complete abscission, and the cholesterol homeostasis, by facilitating normal 
cholesterol efflux and preventing cholesterol accumulation(Schweitzer, Sedgwick, and 
D'Souza-Schorey 2011). 
2.3.2 The ARFs family GEFs 
ARFs proteins are converted into their GTP-bound form by GEFs, which are able to 
displace the GDP and allow the binding of GTP(Gillingham and Munro 2007; Casanova 
2007b). GEFs are fundamental in the precise control of spatial and temporal activation of 
ARFs proteins(Donaldson and Jackson 2011a). Thus, they determine the amount and the 
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localization of active ARFs. All ARFs GEFs share a conserved central domain of a 200 
amino acid sequence named SEC7 that catalyze the nucleotide exchange(Chardin et al. 
1996). The structure of SEC7, either isolated or in complex with ARF1, has been solved 
and shows that an invariant glutamate residue is critical for the catalysis(Goldberg 1998; 
Mossessova, Corpina, and Goldberg 2003; Renault, Guibert, and Cherfils 2003). Most 
GEFs that contain the SEC7 domain are sensible to the fungal metabolite brefeldin A 
(BFA)(Misumi et al. 1986), a drug that blocks secretion of proteins by inhibiting ARF1 
activation and preventing the assembly of coat protein components onto donor membranes. 
The effect of BFA is due to the inhibition of ARF nucleotide exchange by sequestering the 
GEF in an abortive reaction intermediate(Donaldson, Finazzi, and Klausner 1992; 
Peyroche et al. 1999). Indeed, BFA acts through the stabilization and abortion of ARF-
GTP-Sec7 by interacting with residues both on the ARF and on the GEFs(Peyroche et al. 
1999; Robert et al. 2004). 
Based on the presence of the SEC7 domain, mammals have 15 ARFs GEFs that can be 
grouped into six evolutionary conserved families: GBF1, BIG, PSD (PH and SEC7 
domain), IQSEC, Cytohesin and FBXO8 (Table 1)(Gillingham and Munro 2007; 
Donaldson and Jackson 2011a; Casanova 2007b).   
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Table 1. The ARF GTPases family GEFs.  
Modified from(Donaldson and Jackson 2011a). 
 
2.3.2.1 The PSD (EFA6) family  
The PSD, or EFA6 (Exchange Factor for ARF6) family was first identified by Franco and 
colleagues by screening of protein databases for proteins containing the SEC7 
domain(Franco et al. 1999). This family is composed of four members (Fig. 12): PSD 
(EFA6A) and PSD2 (EFA6C), which are expressed predominantly in the brain(Derrien et 
al. 2002; Matsuya et al. 2005), and PSD3 (EFA6D) and PSD4 (EFA6B), which are 
expressed ubiquitously(Derrien et al. 2002; Sakagami et al. 2006). Each member of the 
EFA6 family is encoded by a different gene but in the case of EFA6A(Sironi et al. 2009), 
EFA6C(Matsuya et al. 2005) and possibly EFA6B(Derrien et al. 2002; Luton et al. 2004), 
additional isoforms are generated by alternative splicing. Structurally, each member 
contains a variable N-terminal domain, followed by a central SEC7 domain paired with the 
PH domain, and a C-terminal domain containing a coiled-coil motif (Fig. 11)(Derrien et al. 
2002).  
 
Figure 12. Domain organization of the EFA6 family GEFs 
The Sec7 domain, the PH domain, the coiled-coil (CC) domain and the prolin region (pr) are depicted in 
grey, blu, orange and light blu, respectively. 
Modified from(Casanova 2007b). 
In vitro, the EFA6 family catalyzes guanine nucleotide exchange preferentially on ARF6 
rather than on ARF1(Padovani et al. 2014). EFA6 proteins localize to the PM through the 
PH domain(Franco et al. 1999), which directly binds with high affinity to PI(4,5)P2(Macia 
et al. 2008). This interaction is critical for PM localization and for an efficient exchange 
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factor activity(Macia et al. 2008). The PH domain binds also directly to filamentous actin, 
targeting EFA6 to F-actin-enriched structures at the PM(Macia et al. 2008). The interaction 
with F-actin does not influence nucleotide exchange activity of EFA6(Macia et al. 2008). 
The expression of EFA6 induces rearrangements in the actin cytoskeleton and the 
formation of membrane ruffles by catalyzing GDP/GTP exchange on ARF6 and by 
activating RAC, respectively(Franco et al. 1999). EFA6 has been involved in the 
regulation of endocytic/recycling transport of different PM proteins like the TfR(Franco et 
al. 1999; Boulakirba et al. 2014), the ß2 adrenergic receptor(Macia et al. 2012) and the K+ 
channel Twik1(Decressac et al. 2004). Recently, EFA6B and EFA6D have been shown to 
be involved in the regulation of ß1 integrin recycling. Indeed, their removal blocks the 
HGF-induced ß1 integrin recycling in endothelial cells, similar to ARF6 
knockdown(Hongu et al. 2015). 
EFA6 function has been linked to development and maintenance of cell polarity in 
epithelial cells by the Luton group(Luton et al. 2004; Klein et al. 2008; Theard et al. 2010): 
they showed that the expression of EFA6A in MDCK cells accelerates the de-novo 
formation of actin cytoskeleton and a functional tight junction (TJ)(Luton et al. 2004). 
Molecularly, EFA6 is recruited by E-cadherin and participates to the establishment of cell 
polarity by stabilizing the apical actin ring, which becomes the platform where TJ 
molecules are anchored(Luton et al. 2004). EFA6 effects depend on both its exchange 
activity by the SEC7 domain and its actin remodeling activity of the C-terminal domain. 
Also, active ARF6 participates in this process through the C-terminal domain of 
EFA6(Klein et al. 2008). Simultaneous expression of a constitutively active ARF6 mutant 
and the C-terminal of EFA6 mimic the modification induced by EFA6 full length during 
TJ assembly(Klein et al. 2008). The same group has also characterized a novel regulatory 
pathway for TJ formation involving EFA6 and its stabilization by the deubiquitinase 
USP9X(Theard et al. 2010): they found that, in MDCK cells, EFA6B levels are critical for 
the rate of TJ formation. In fact, EFA6 protein levels are maintained at steady state by its 
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constitutive ubiquitination and are augmented before TJ formation due to deubiquitination 
by USP9X. Moreover, USP9X is transiently localized at early cell-cell contact sites to 
allow the spatially and temporally regulated increase of EFA6B levels.  
The mechanisms that regulate EFA6 activity are different from those that regulate 
cytohesin activity, whose PH domain is autoinhibitory and supports a positive feedback 
loop(Padovani et al. 2014). Recently, it has been demonstrated that the PH domain of 
EFA6 is not autoinhibitory but supports a negative feedback loop, which is regulated by 
the interaction of ARF6 GTP with the PH- and the C-terminal domains of EFA6(Padovani 
et al. 2014). Although previous studies found that EFA6 is not able to activate ARF1 in 
vitro, it was found to efficiently activate ARF1 in the presence of liposomes(Padovani et 
al. 2014).  
More recent findings have highlighted a role for EFA6 GEFs in breast cancer(Zangari et al. 
2014) and in clear cell renal cell carcinoma ccRCC(Hashimoto et al. 2016). In breast 
cancer, EFA6B has been shown to act as an antagonist at an early stage of development by 
preventing TJ disassembly and loss of epithelial polarity(Zangari et al. 2014). In vivo 
breast cancer analysis revealed that loss of EFA6B correlates with poor prognosis and 
associates with Triple Negative Breast Cancer (TNBC) and Claudin-low subtypes(Zangari 
et al. 2014). In vitro, EFA6B antagonizes TGFß-induced EMT and maintains the epithelial 
apico-basal polarity of mammary acini. Thus, EFA6B appears to be a potential tumor 
antagonist whose down-regulation may promote breast cancer progression(Zangari et al. 
2014). In ccRCCs, LPA activates, through its GPCRs, ARF6 and EFA6 to sustain 
mesenchymal-type of invasion, metastasis and drug resistance. In this situation, all 
members of the EFA6 family, except for EFA6D, appear to be potential activators of 
ARF6 upon LPA stimulation to promote cell invasion. This function of EFA6 is mediated 
by interaction with the GTP-Gα12, a GPCR(Hashimoto et al. 2016).  
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3 AIM OF THE STUDY 
Cells are able to respond to spatial information by adopting their cytoskeleton architecture 
and maintaining asymmetric and polarized distribution of molecules whose signaling 
outputs are spatially restricted. Thus, spatial restriction of signaling is a fundamental tool 
for the cell to perform a variety of processes, including directional cell migration, cell-fate 
decision, epithelia-cell polarization, growth cone movement, tissue morphogenesis during 
development, and tumor/cancer cell invasion into the surrounding tissues and metastasis 
(Disanza et al. 2009).  
Endocytosis/recycling of membrane and membrane-bound proteins is a process strictly 
connected with signaling, controlling its intensity and its specificity by spatially confining 
signaling outputs where these occur.  
During directional migration, polarized recycling of endosomes is required for the 
maintenance of cell polarity during cell migration. A similar mechanism is also required 
for the generation of different kinds of migratory protrusions induced upon receptor 
tyrosine kinase RTK stimulation, such as Peripheral Ruffles (PRs) and CDRs(Buccione, 
Orth, and McNiven 2004). To find out novel endocytic/trafficking proteins involved in 
directional cell migration, we performed an RNAi screening using PRs and CDRs as 
readout markers. We found that the endocytic adaptor protein NUMB is as a negative 
regulator of CDR formation but does not affect PR formation.  
The protein NUMB is a cell fate determinant and acts as a tumor suppressor. Indeed, loss 
of NUMB occurs in about 50% of all breast tumors(Pece et al. 2004) and in 30% of all 
lung cancers(Westhoff et al. 2009), and correlates with a decreased activity of p53, and/or 
an increased activation of NOTCH(Pece et al. 2004; Westhoff et al. 2009). As an endocytic 
adaptor protein, NUMB interacts with key players of the CME via its NPF and DPF 
motives, which mediate the association with EHD containing proteins, such as Eps15, and 
α adaptin, a subunit of the AP2 complex, respectively(Santolini et al. 2000). NUMB also 
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localizes in recycling endosomes where it controls the delivery of cargos back to the PM in 
various organisms(Smith et al. 2004; Nilsson et al. 2008; Nilsson, Jonsson, and Tuck 2011; 
McGill et al. 2009; Rasin et al. 2007). Consistently, the C. Elegans and Drosophila NUMB 
homologs are negative regulators of membrane recycling(Nilsson et al. 2008; Nilsson, 
Jonsson, and Tuck 2011; Cotton, Benhra, and Le Borgne 2013; Couturier, Mazouni, and 
Schweisguth 2013). In mammalian cells, NUMB was shown to regulate post-endocytic 
sorting of NOTCH-1(McGill et al. 2009). Finally, NUMB and EHD-containing proteins 
are physically localized in recycling vesicles containing the ARF6 GTPase(Smith et al. 
2004). The molecular mechanism by which NUMB acts in the recycling pathway has not 
been clarified yet.  
Based on results from our laboratory that demonstrate that NUMB is a negative regulator 
of CDRs (unpublished data), whose formation requires endocytic trafficking of RAC via 
ARF6(Palamidessi et al. 2008), and that NUMB functions in the recycling compartment 
are ill-defined, the main aim of this thesis was to further characterize the molecular 
mechanism beyond this novel NUMB function. 
Since CDRs are sites of fluid phase endocytosis and necessary for cell migration within a 
3D matrix(Buccione, Orth, and McNiven 2004), we aimed to clarify the link between the 
endocytic functions of NUMB and its tumor suppressor role using a mechanistic approach. 
Indeed, NUMB may control recycling of key cargos, the fate of which may regulate cell 
signaling, leading to the acquisition of migratory and invasive phenotypes of tumor cells. 
Our approach will, thus, allow us to understand how NUMB is involved in growth factor-
dependent mesenchymal cell motility and how this affects the tumor suppressive role of 
NUMB. Our studies have shed light on how loss of NUMB contributes to the combined 
disruption of pathways that regulate both stem cell homeostasis and cell motility, favoring, 
thus, the generation of tumors with an aggressive phenotype. 
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4 RESULTS 
4.1 NUMB is a negative regulator of CDR formation downstream 
growth factor activation 
Growth factor-induced CDRs represent a surrogate marker preceding the acquisition of 
mesenchymal mode of cell migration(Palamidessi et al. 2008). CDRs structures are an 
“easy-to-follow read out” that can be detected through low-magnification phase-contrast 
time-lapse microscopy(Palamidessi et al. 2008). It has been demonstrated that a tripartite 
signaling cascade, originating from RAB5, PI3K, and RAC, must simultaneously operate 
to allow the formation of CDRs(Lanzetti et al. 2004). In epithelial cells, the ectopic 
expression of RAB5 activates RAC in a Dynamin-dependent manner and induces CDRs. 
Additionally, inhibition of CME and interference with recycling abrogates HGF-, and 
RAB5-induced CDRs formation(Palamidessi et al. 2008). Collectively, these results 
demonstrate that RAB5, by controlling the endo-/exocytic cycles (EEC) of RAC, spatially 
restricts RAC signaling, generating the formation of polarized, migratory 
protrusions(Palamidessi et al. 2008). 
In order to assess the impact of endocytic/trafficking proteins on mesenchymal mode of 
motility in a 2D environment, an RNAi screening was set up and CDRs and PRs were used 
as read-out markers. First, we confirm that blocking of CME by clathrin and dynamin 
RNAi blocks CDRs formation(Palamidessi et al. 2008; Frittoli et al. 2014) (Tab. 2). As 
previously demonstrated, in absence of RAB5, RAC and TIAM neither CDRs nor PRs are 
formed (Tab. 2)(Frittoli et al. 2014; Palamidessi et al. 2008). Among all the candidates, we 
noticed the removal of the endocytic adaptor NUMB, Caveolin-1 and the F-BAR 
containing proteins Toca1/FBP1/CIP4 increase CDRs formation, while does not impairs 
PRs formation (Tab. 2). Since NUMB is one of the main focus of our research group, we 
decided to further investigate this novel function of NUMB. To begin, we confirmed that 
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NUMB is a negative regulator of CDR formation downstream of C-Met activation in HeLa 
cells by its transient silencing with four independent oligos (Fig. 13).  
 
RNAi gene Circular dorsal 
ruffles (CDRs) 
Peripheral 
ruffles (PR) 
Dynamin Inhibited  Inhibited 
Clathrin Inhibited Inhibited 
Caveolin-1 Increased Unchanged 
Eps15/Eps15r Unchanged Unchanged 
AP-2 Inhibited Inhibited 
Rab5 Inhibited Inhibited 
Numb Increased Unchanged 
Toca1/FBP1/CIP4 Increased Unchanged 
Arf6 Inhibited Inhibited 
Rab35 Inhibited Inhibited 
Rab4 Unchanged Unchanged 
Rab11 Unchanged Unchanged 
Rab43 Unchanged Unchanged 
Rab30 Unchanged Unchanged 
Exo70 Unchanged Unchanged 
   
Tiam-1 Inhibited Inhibited 
Sos-1 Inhibited Unchanged 
Rac Inhibited Inhibited 
Cdc42 Inhibited Unchanged 
   
Abi-1 Inhibited Inhibited 
WAVE2 Inhibited Inhibited 
N-WASP Unchanged Unchanged 
Eps8 Unchanged Unchanged 
IRSp53 Reduced Unchanged 
ß1 Unchanged Unchanged 
 
Table 2. RNAi screening of endocytic/trafficking proteins affecting RTK-induced CDRs and PRs.  
Analysis of CDR and PR formation upon stimulation with motogenic factors (such as HGF and/or EGF) 
of HeLa cells. (See Materials and Methods for a detailed description of the experimental settings.) 
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Figure 13. Silencing of NUMB increases HGF-induced CDR formation.  
A. HeLa cells transfected with four different siRNA (N3, NN, N5, N6) against NUMB or scramble 
oligo (si CTR) as control were seeded on matrigel-coated coverslips. After 48 hours, cells were serum 
starved (SS) for 2 hours stimulated with 100 ng/mL HGF for 4 minutes, fixed and stained with F-actin 
antibody. Scale bar: 20 µm. Right panel: the number of cells forming CDR over the total number of 
cells per field. At least 20 fields were analyzed in each condition and three independent experiments 
were performed. Representative images are shown. The data are presented as the mean ± SEM 
(Standard Error of the Mean).  
B. The expression levels of NUMB and vinculin were analyzed by immunoblotting (IB). Molecular 
Weight (MW) markers are shown on the left of the blots. 
To strengthen the notion that NUMB acts downstream the activation of an RTKs, such as 
C-Met, and negatively regulates CDR formation, Mouse Embryonic Fibroblasts (MEFs), a 
very well characterized system for CDR formation upon PDGF receptor 
activation(Buccione, Orth, and McNiven 2004), were employed. NUMB ablation by 
transient RNAi in this cellular system increases the number of cells forming CDRs upon 
PDGF stimulation (Fig. 14). These results confirm that NUMB is indeed a negative 
regulator of CDR formation downstream C-Met and PDGFR activation.  
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Figure 14. Silencing of NUMB increases PDGF-induced CDR formation.  
A. MEF cells transfected with three different siRNA (Numb #2, Numb #3, Numb #4) against NUMB or 
scramble oligo (si CTR) as control were seeded on gelatin-coated coverslips. After 24 hours, cells were 
serum starved (SS) for 2 hours, stimulated with 1 ng/mL PDGF for 8 minutes, fixed and stained with F-
actin antibody. Scale bar: 20 µm. Right panel: the number of cells forming CDR over the total number 
of cells per field. At least 20 fields were in analyzed in each condition and three independent 
experiments were performed. Representative images are shown. The data are the mean ± SEM.  
B. The expression level of NUMB and vinculin were analyzed by IB. MW markers are shown on the 
left of the blots. 
4.2 Re-expression of NUMB in MEF cells rescues CDR formation 
The mammalian Numb gene is transcribed in 4 different splicing variants due to the 
alternate splicing of two exons, one in the PTB domain and another in the C-terminal 
region(Verdi et al. 1999) (see section 2.2.1).  
All isoforms were silenced by RNAi with the oligos described above (Fig. 13 and 14). To 
investigate whether all four isoforms share the same function on CDR formation, MEFs 
interfered for NUMB were transfected either with GFP empty vector (control) or with the 
four GFP-fused human NUMB isoforms. Our results showed that all four NUMB human 
isoforms, when expressed, were able to revert the increase in CDR formation due to 
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endogenous NUMB ablation (Fig. 15), once again confirming that NUMB is a negative 
regulator of these migratory protrusions. 
Figure 15. Re-expression of NUMB in MEF cells rescues CDR formation.  
A. MEF cells interfered with a scramble oligo (siCTR) as control, or with siRNA against NUMB 
(Numb #3, upper panels), or interfered with siRNA against NUMB (Numb #3) and transfected with 
GFP empty vector or GFP-NUMB isoform 1, 2, 3 and 4 (upper-lower panels) were seeded on gelatin-
coated coverslips. After 24 hours, cells were serum starved (ss) for 2 hours, and stimulated with 1 
ng/mL PDGF for 8 minutes, fixed and processed for epifluorescence to visualize GFP or GFP–NMB 
(green, where indicated) and stained with F-actin antibody (red). Scale bar: 20 µm (10 µm in GFP or 
GFP-NUMB panels).  
B. Left panel. The percentage of cells forming CDR over the total number of cells per field was 
counted. At least 20 fields were analyzed in each condition and three independent experiments were 
performed. Representative images are shown. The data are presented as the mean ± SEM.  Right panel. 
The expression levels of NUMB and vinculin were analyzed by IB. MW markers are shown on the left 
of the blots. 
4.3 NUMB is a negative regulator of HGF-induced cell migration and 
invasion 
CDR formation correlates with mesenchymal migration(Palamidessi et al. 2008). We 
investigated whether NUMB could have an impact on cell migration in 2D and 3D cell 
cultures upon growth factor-induced stimulation of RTKs, for assessment of cell migration 
and invasion, respectively. NUMB RNAi resulted in an increased cell elongation index (a 
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ratio between the major axis and the minor axis), which directly correlates with 
mesenchymal cell locomotion(Palamidessi et al. 2008), and was accompanied by a 
concomitant increase in the migration and in the velocity of NUMB depleted cells 
compared to control cells (Fig. 16).   
Figure 16. Silencing of NUMB promotes HGF induced cell migration.  
A. HeLa cells were transfected with a siRNA against NUMB (Numb KD) or scramble oligo (si CTR) as 
control. After 48 hours, cells were serum starved (ss) for 2 hours, stimulated with 100 ng/mL HGF and 
analyzed by time-lapse microscopy for 19 hours. Representative images for each condition at specific 
time points (0h, 6h30min, 12h30min, 19h) are shown. Scale bar: 20 µm 
B. Upper panel. Elongation index (ratio between the major and the minor axis) was quantified for each 
condition at the indicated time points. Lower panels. Total distance accumulated by cells (left graph) 
and mean velocity (right panel) were measured. The analysis was conducted on at least 30 single 
cells/experiment of three independent experiments. The data are presented as the mean ± SEM.  
C. The expression levels of NUMB and vinculin were analyzed by IB. MW markers are shown on the 
left of the blots. 
We next investigated the role of NUMB in cell motility in a 3D matrix. Matrigel-coated 
boyden chambers were employed and HGF was used as chemoattractant.  We found that 
removal of NUMB by siRNA promoted cell invasion (Fig. 17). Collectively, these 
observations support the notion that NUMB acts as a negative regulator of c-MET-induced 
mesenchymal motility. Accordingly, NUMB has recently been shown to control ill-defined 
recycling pathways, which is in turn necessary for the integrity of adherent junctions and 
for the acquisition of migratory properties and EMT features(Wang et al. 2009). 
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Figure 17. Silencing of NUMB promotes HGF-induced cell invasion.  
A. HeLa cells transfected with siRNA against NUMB (si N3, si NN) or scramble oligo (si CTR) as 
control were seeded on matrigel-coated chambers. 100 ng/ml HGF was added in the lower chamber to 
generate a chemo-attractive gradient. After 24 hours, cells were fixed, stained with rodhamine 
phalloidin antibody to detect actin and analyzed by confocal microscopy. Representative images of 
upper, non-invasive cells (left panels) and lower, invasive cells (right panel) are shown. Scale bar: 40 
µm. 
B. Quantification of the number of cells passing through the semi-permeable membrane is shown as 
fold increase compared to control cells. At least 10 fields were analyzed for each condition. The data are 
presented as the mean ± SEM. from three independent experiments.  
C. The expression levels of NUMB and vinculin were analyzed by IB. MW markers are shown on the 
left of the blots. 
4.4 NUMB localized in RAB5/ARF6 induced enlarged endosomes 
The small GTPase RAB5 is a key regulator of CDR formation(Lanzetti et al. 2004; 
Palamidessi et al. 2008). RAB5 controls endocytic/endosomal dynamics and is activated 
upon ligand-bound RTKs, leading to the trafficking of RAC1 and its GEF TIAM1 to early 
endosomal compartments via CME(Palamidessi et al. 2008). There, RAC1 undergoes 
activation and is recycled back to specific region of the PM, via ARF6, where it promotes 
CDR formation(Palamidessi et al. 2008). Since NUMB, as an endocytic protein, localizes 
in the recycling compartment(Smith et al. 2004) and is emerging as a negative regulator of 
recycling in C. Elegans(Nilsson et al. 2008; Nilsson, Jonsson, and Tuck 2011) and 
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Drosophila(Cotton, Benhra, and Le Borgne 2013; Couturier, Mazouni, and Schweisguth 
2013), one possibility is that NUMB may have an impact on the ARF6-dependent 
recycling pathway of RAC1 to the PM. We therefore assessed the subcellular localization 
of NUMB, focusing our attention on the EE and on the ARF6 recycling compartment. We 
found that NUMB is enriched in EE when induced by RAB5 ectopic expression (Fig. 
18A), and in enlarged endosomes when induced by the expression of dominant active 
ARF6 (ARF6 Q67L) (Fig. 18B).  
Figure 18. NUMB is enriched in RAB5/ARF6 induced enlarged endosome.  
A. Upper panels: confocal analysis of HeLa cells transfected with Rab5. 24 hours after transfection, 
cells were fixed and stained with EEA1 (red), RAB5 (magenta) and NUMB (green) specific antibodies 
to visualize Rab5-induced enlarged endosomes and Numb localization. Scale bar: 20 µm 
Lower panels: 4X magnification of the selected area.  
B. Upper panels: confocal analysis of HeLa cells transfected with ARF6 Q67L. 24 hours after 
transfection, cells were fixed and stained with F-actin (green) or Numb (red) specific antibodies to 
visualize ARF6-induced enlarged endosomes and NUMB localization. Scale bar: 20 µm. 
Lower panels: 4X magnification of the selected area.  
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4.5 NUMB is a negative regulator of ARF6-dependent recycling 
pathway 
To study whether the localization of NUMB in enlarged endosomes, induced by ARF6, has 
a functional role, we decided to investigate if removal NUMB has an impact on the 
recycling of cargos routed back to the PM specifically via ARF6, like MHC class 
I(Schweitzer, Sedgwick, and D'Souza-Schorey 2011). We found that depletion of NUMB 
increases the rate of recycling of MHC class I (Fig. 19). 
Figure 19. NUMB negatively regulates MHC I, ARF6 dependent recycling. 
Left panel: FACS analysis. HeLa cells were transfected with siRNA against NUMB (si N3, si NN) or 
scramble oligo (si CTR). 48 hours after transfection, cells were incubated with MHC-I specific antibody 
for 3 hours at 16˚C to allow internalization and avoid recycling and to allow the binding of the antibody 
to the cell surface. Finally, cells were stripped with acid wash (pH 2,5) and analyzed directly (t=0) or 
released at 37˚C for 5, 20 and 60 minutes and then analyzed by FACS using MHC-I specific antibody to 
detect the amount of MHC-I recycled back to the cell surface. The assay was repeated three times and 
representative data of a single experiment are shown. 
Right panel. The expression levels of NUMB and vinculin were analyzed by IB. MW markers are 
shown on the left of the blots. 
The formation of CDRs requires the recycling of active RAC1 back to the PM via 
ARF6(Palamidessi et al. 2008). We therefore investigated whether NUMB has an impact 
on this critical step. We observed that ectopic expression of NUMB strongly decreased 
RAC1 recycling compared to control cells (Fig. 20). These data, together, demonstrate that 
NUMB is a negative regulator of ARF6-dependent recycling pathway.  
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Figure 20. NUMB negatively regulates RAC-1, ARF6 dependent recycling.  
A. HeLa cells were co-transfected with paGFP RAC and Numb Red or empty vector. paGFP barely 
absorbs 488 nm light in its native form, thereby exhibiting a weak fluorescence emission. Focal plane-
restricted, multiphoton-induced photoactivation of paGFP-RAC was achieved by exciting the area 
corresponding to a vesicle. Images were then collected every 20 seconds (exciting fluorescence at 488 
nm). Right panels: Numb Red epifluorescence images are shown. Scale bar: 10 µm. 
B. The increase in fluorescence over time in a target region of the PM adjacent to the photoactivable 
vesicle. The data are presented as the mean ± SEM of 27 and 25 events counted for the empty vector 
(control) and NUMB (mRed-Numb) transfected cells, respectively. 
4.6 NUMB binds to EFA6 B, a GEF for ARF6 
Like all small GTPases, ARF6 cycles between its active-GTP-bound and its inactive-GDP-
bound conformations(Donaldson and Jackson 2011b). Guanine nucleotide exchange 
factors, GEFs, activate ARF6 by mediating exchange of GTP for GDP, whereas GTPase 
activating proteins, GAPs, down-regulate ARF6 activity through hydrolysis of GTP to 
GDP(Donaldson and Jackson 2011b). Since GEFs are the primary regulatory target of 
small GTPases(Donaldson and Jackson 2011b), we investigated whether NUMB could 
interact with a GEF for ARF6. Among all GEFs for ARF6, we focused our attention on 
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those that have been reported to control actin remodeling (see section 2.3.2), in particular 
on the EFA6 A-D and Cytohesin family of GEFs. These two subfamilies have been 
reported to control actin remodeling(Casanova 2007b; Gillingham and Munro 2007), 
which is required for the formation of CDRs and cell migration(Hoon, Wong, and Koh 
2012). We tested which of these GEFs are expressed in our experimental model systems 
(HeLa and MEF cells) by qPCR analysis. We found that all Cytohesin (ARNO) family 
members are present, while only EFA6B and EFA6D are expressed in our model systems 
(Tab. 2). 
GENE CT GAPDH  GENE CT GAPDH 
EFA6A 34.7 18.0  EFA6A 33.5 18.2 
EFA6C not detectable 18.0  EFA6C 34.5 18.2 
EFA6D 27.6 18.0  EFA6D 28.3 18.2 
EFA6B 29.9 18.0  EFA6B 31.8 18.2 
Cytohesin 1 26.9 19.5  Cytohesin 1 28.3 18.2 
Cytohesin 2 26.9 19.5  Cytohesin 2 26.5 18.2 
Cytohesin 3 27.8 19.5  Cytohesin 3 25.5 18.2 
 
Table 3. q-PCR Analysis of mRNA levels of EFA6 and Cytohesin family members. 
Left table: HeLa cells. 
Right table: MEF cells. 
To test which of these GEFs may bind NUMB we performed a pull-down assay. We found 
that EFA6 B, but not EFA6D and ARNO, is able to bind NUMB via its PTB domain (Fig. 
21). 
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Figure 21. NUMB interacts with EFA6B.  
Lysates (2.5 mg) from Phoenix cells transfected with pEGFP EFA6B, pEGFP EFA6D or pEYFP 
ARNO were incubated with 0.5 µM GST, GST NUMB, or GST-NUMB PTB domain immobilized on 
beads as indicated. Input lysates (2% of the total) and bound material were analyzed by IB with anti-
GFP to visualize EFA6B, EFA6 D and ARNO or by Ponceau staining to detect the recombinant GST 
proteins. GST-NUMB was incubated either with cell lysate or with lysis buffer to evaluate any possible 
IB non-specific signal. MW markers are shown on the left of the blots. 
To investigate if the NUMB C-terminal region is involved in the interaction, we then 
performed a pull-down assay, using two NUMB constructs that cover this region, the 
Proline Reach Region 1 (PRR1) and the Proline Reach Region 2 (PRR2), respectively, as a 
bait (Fig. 22A). Our results confirmed that only EFA6B interacts with the NUMB PTB 
domain (Fig 22B).  
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Figure 22. EFA6B interacts with NUMB PTB.  
A. Schematic representation of NUMB deletion fragments.  
B. Lysate (2.5 mg) from Phoenix cells transfected with pEGFP EFA6B was incubated with 0.5 µM 
GST, GST NUMB FL, GST NUMB PTB (20-175 aa), GST NUMB PRR1 (175-339aa), or GST NUMB 
PRR2 (339-651aa) immobilized on beads as indicated. Input lysates (1% of the total) and bound 
material were analyzed by IB with anti-GFP to visualize EFA6B, EFA6 D and ARNO or by Ponceau 
staining to detect the recombinant GST proteins. MW marker is shown on the left of the blot. 
To detect in situ protein:protein interactions(Soderberg et al. 2006), HeLa cells expressing 
NUMB-FLAG and EFA6B-GFP or NUMB-FLAG and GFP (control) were analyzed by 
proximity ligation approaches (see Materials and Methods for details). We were able to 
score proximity ligation signal in 30% of NUMB-FLAG and EFA6B-GFP co-transfected 
cells, while only 3% of NUMB-FLAG and GFP control cells were positive (Fig. 23). 
Additional negative controls, HeLa cells expressing only NUMB-FLAG or EFA6B-GFP, 
or both NUMB-FLAG and EFA6B-GFP processed without primary antibodies, were 
analyzed by proximity ligation but did not result in any signal.  
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Figure 23. In situ protein:protein interactions between NUMB and EFA6B.  
Upper, left panel: HeLa cells co-transfected with NUMB-FLAG and EFA6B-GFP or GFP alone 
(control) were fixed and stained with anti-FLAG monoclonal and anti-GFP polyclonal antibodies. The 
signals were detected by Duolink® 30 Detection Kit 613 (red), and the nuclei were counterstained with 
DAPI (blue). Red dots represent the detection of protein-protein interaction.  
Upper, right panel: quantification of Duolink positive cells over the total number of GFP positive cells. 
Three independent experiments were performed and at least 100 cells were counted for each condition. 
The data are presented as the mean ± SEM.  
Lower, left and middle panel: HeLa cells transfected with NUMB-FLAG and EFA6B were fixed and 
stained with anti-FLAG monoclonal and anti-GFP polyclonal antibodies. The signals were detected by 
Duolink® 30 Detection Kit 613 (red), and the nuclei were counterstained with DAPI (blue).  
Lower, right panel: HeLa cells co-transfected with NUMB-FLAG and EFA6B-GFP were fixed and 
directly processed with Duolink® 30 Detection Kit 613 (red). The nuclei were counterstained with 
DAPI (blue). Scale bar: 20 µm. 
To verify if the interaction between NUMB and EFA6B is regulated by growth factors, we 
performed Co-IP experiments. 293T cells were transfected with GFP-EFA6B and NUMB-
FLAG or an empty vector as a control and stimulated or not with growth factors. The 
expression of NUMB-FLAG resulted in FLAG immunoprecipitates containing EFA6B 
(Fig. 24) and the interaction is not modulated by growth factors, as shown by equal level of 
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EFA6B with or without growth factors stimulation by IB analysis. Of note, the efficacy of 
growth factors stimulation was confirmed by the activation of downstream pathways. 
Figure 24. The interaction between NUMB and EFA6B is not modulated by growth factor 
stimulation.  
Phoenix cells transfected with GFP-EFA6B and NUMB-FLAG or an EV-FLAG (control) were serum 
starved for 4 hours (-) and stimulated for 5 minutes with 100 ng/mL HGF and EGF. 1.5 mg of total cell 
lysate for each condition were immunoprecipitated with anti-FLAG M2 affinity gel (2 rounds with 15 
µL) or anti-MYC as control. Inputs (1%) and immunoprecipitates were analyzed by Western blot (WB) 
analysis and IB with indicated antibodies. MW markers are shown on the left of the blots. 
Finally, to test if the interaction between NUMB and EFA6B is direct, we performed a 
pull-down assay employing recombinant purified proteins. Our results indicate that EFA6B 
binds directly to NUMB, as shown by IB (Fig. 25). These results support the notion that 
NUMB may regulate ARF6-dependent recycling by binding and possibly modulating its 
GEF EFA6B. 
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Figure 25. EFA6B binds to NUMB.  
Purified NUMB-His at 0.5 µM was incubated or not with 0.5 µM MBP EPS8 C-terminal or MBP 
EFA6B immobilized on beads as indicated. Input (1/5) and bound material were analyzed by IB with 
anti-Numb to visualize NUMB or Ponceau staining to detect MBP recombinant protein. MW markers 
are shown on the left of the blot. 
4.7 The N-terminal domain and the C-terminal domains of EFA6B are 
required for the interaction with NUMB 
The most conserved element in the EFA6 family is the C-terminal region, which contains a 
SEC7 domain flanked by a PH domain, followed by a ~150 amino-acid region carrying a 
putative coiled-coil motif (Fig. 26A)(Derrien et al. 2002). Additionally, among the 
members of the EFA6 family, EFA6B contains a long N-terminal region. To identify the 
EFA6B regions required for the interaction with NUMB, we generated different deletion 
constructs (Fig. 26A) and tested them in a pull-down assay using GST-NUMB as bait or 
GST alone as a control. We found that the N-terminal domain of EFA6B (1-554 aa) 
strongly binds to NUMB, at levels comparable to the full length protein, while the C-
terminal region (555-1056 aa) retains a weaker interaction. Of note, the Sec7 domain alone 
(555-738 aa) is not able to bind NUMB. The PH domain and the coild-coiled region (739-
1056) display a weak interaction with NUMB, comparable to the entire C-terminal region 
(555-1056 aa) (Fig. 26B).  
 
 
 73 
Figure 26. Identification of EFA6B surface required to bind NUMB.  
A. Schematic rapresentation of EFA6B. The Sec7 domain, the PH domain and the coiled coil domain 
are depicted in red, blu and yellow, respectively. Deletion mutants are indicated below the schematic 
representation.  
B. Lysates (1.5 mg) from Phoenix cells transfected with pEGFP-EFA6B FL or its deletion mutants were 
incubated with 0.5 µM GST or  GST-NUMB immobilized on beads as indicated. Input lysates (1% of 
the total)  and bound material were analyzed by IB with anti-GFP to visualize EFA6B and its deletion 
mutants or by Ponceau staining to detect the recombinant GST proteins. MW markers are shown on the 
left of the blots. 
4.8 The NPxF domain motif in the N-terminal of EFA6B is required for 
the binding of NUMB via its PTB 
Analysis of the amino acid sequence of EFA6B revealed the presence in the N-terminal 
region of an NPxF (248-251 aa) consensus motive for binding to NUMB (Qin et al. 2004; 
Bogdanovic et al. 2012). To check whether this consensus motif is required for the 
interaction, we generated two deletion mutants in the context of EFA6B N-terminal region 
(1-554 aa). The first mutant (1-255 aa) contains the NPxF stretch, while the second mutant 
(256-554 aa) does not. We found that only the 1-256 aa fragment was able to bind NUMB 
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as the whole N-terminal region (1-554 aa) in a pull-down assay (Fig. 27A), suggesting that 
this consensus motif is required for the interaction. To confirm this finding, we generated 
single point mutants (N248A and F251A) alone or in combination in the contest of the 
EFA6B N-terminal region (1-554 aa). We found that only the WT EFA6B 1-554 aa was 
able to bind NUMB in a pull-down assay, while the interaction with proteins carrying the 
single point mutations alone or in combination was strongly impaired (Fig. 27B). 
Figure 27. The NPxF domain in the N-terminus of EFA6B is required for binding to NUMB via 
PTB.  
A. Lysates (1.5 mg) from Phoenix cells transfected with pEGFP-EFA6B 1-554, pEGFP-EFA6B 1-255 
or pEGFP-EFA6B 256-554 were incubated with 0.5 µM GST or GST-NUMB immobilized on beads as 
indicated. Input lysates (1% of the total) and bound material were analyzed by IB with anti-GFP to 
visualize EFA6B and its deletion mutants or by Ponceau staining to detect the recombinant GST 
proteins. MW markers are shown on the left of the blots. 
B. Lysates (750 µg) from Phoenix cells transfected with pEGFP-EFA6B 1-554 WT, N248A, F251A or 
N248A F251A were incubated with 0.5 µM GST, GST-NUMB or GST PTB immobilized on beads as 
indicated. Input lysates (2% of the total) and bound material were analyzed by IB with anti-GFP to 
visualize EFA6B and its deletion mutants or by Ponceau staining to detect the recombinant GST 
proteins. MW markers are shown on the left of the blots. 
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These findings were confirmed in a set of pull-down assays using purified proteins. A 
titration curve was carried out to establish the minimal amount of NUMB in solution that 
allows detection of the binding with GST-EFA6B (Fig. 28A). In these conditions, an 
EFA6B construct carrying the N248A and F251A mutations in the NPxF motif showed 
reduced binding to recombinant purified NUMB compared to WT GST-EFA6B (Fig. 
28B). Equal results were obtained in an in vitro pull-down assay using purified 
recombinant NUMB PTB (Fig. 29). 
Figure 28. EFA6B binds to NUMB via its NPxF motif.  
A. Increasing amounts (0, 0.05, 0.5 and 5 µM) of purified Numb-His were incubated with 0.5 µM GST-
EFA6B 1-738 or GST alone (control) immobilized on beads as indicated. Input (0.05 µM) and bound 
material were analyzed by IB with anti-Numb to visualize NUMB or anti-GST staining to detect GST 
recombinant protein. MW marker is shown on the left of the blots. 
B. Purified Numb-His (0.05 µM) was incubated with 0.5 µM GST-EFA6B 1-739 WT or N248A, 
F251A mutant or GST alone (control). Input (1/5) and bound material were analyzed by IB with anti-
Numb to visualize NUMB or Ponceau staining to detect GST recombinant proteins. MW markers are 
shown on the left of the blots. 
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Figure 29. EFA6B binds to NUMB PTB via its NPxF motif.  
Increasing amounts of Numb PTB-His (0, 0.01, 0.05, 0.25) were incubated with 0.5 µM GST-EFA6B 1-
739 WT, or N248A, F251A mutant or GST alone (control) as indicated. Input (10 nM) and bound 
material were analyzed by IB with anti-His to visualize NUMB PTB or Ponceau staining to detect GST 
recombinant protein. M markers are shown on the left of the blots. 
To investigate whether the N248A and F251A mutations affect the ability of EFA6B full-
length protein to binds NUMB, we performed a pull-down assay to compare the WT 
EFA6B with the N248A and F251A mutant. We found that the EFA6B N248A and F251A 
mutant is strongly defective in binding to NUMB and is not able to bind the PTB (Fig. 30). 
All together, these experiment confirm that the NPxF sequence in the N-terminal of 
EFA6B mediates the binding with NUMB PTB. 
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Figure 30. EFA6B carrying the mutation in the NPxF motifs is impaired in its binding to NUMB.  
Lysates (2 mg) from Phoenix cells transfected with pEGFP-EFA6B WT or pEGFP-EFA6B N248A-
F251A were incubated with 0.5 µM GST, GST-NUMB or GST-PTB immobilized on beads as 
indicated. Input lysates (2% of the total) and bound material were analyzed by IB with anti-GFP to 
visualize EFA6B or by Ponceau staining to detect the recombinant GST proteins. MW markers are 
shown on the left of the blot. 
4.9 EFA6B localizes in enlarged endosome induced by ARF6 dominant 
active expression 
Since EFA6B is a GEF for ARF6(Donaldson and Jackson 2011b), we analyzed its sub-
cellular localization in steady state conditions and in respect to the ARF6 recycling 
compartment. As previously reported(Derrien et al. 2002), we found that EFA6B is 
expressed in the cytosol and is enriched at the PM (Fig. 31). The expression of dominant 
active ARF6 (Q67L) induces the formation of enlarged endosomes, were EFA6B and 
NUMB re-localize (Fig. 32 and 18B). 
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Figure 31. EFA6B is enriched at the PM.  
A. Upper panels: confocal analysis of HeLa cells transfected with GFP. 24 hours after transfection, cells 
were fixed and processed for epifluorescence analysis to visualize GFP (green) or stained with anti 
EEA1 to visualize the early endosomal compartment (red) and DAPI (blue) to visualize the nuclei. 
Scale bar: 20 µm. 
Lower panels: 5X magnification of the selected area.  
B. Upper panels: confocal analysis of HeLa cells transfected with GFP-EFA6B. 24 hours after 
transfection, cells were fixed and processed for epifluorescence analysis to visualize GFP-EFA6B 
(green) or stained with anti EEA1 to visualize the early endosomal compartment (red) and DAPI (blue) 
to visualize the nuclei. Scale bar: 20 µm. 
Lower panels: 5X magnification of the selected area.  
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Figure 32. EFA6B stains enlarged endosomes induced by active ARF6.  
A. Upper panels: confocal analysis of HeLa cells transfected with GFP and HA-Arf6:Q67L. 24 hours 
after transfection, cells were fixed and processed for epifluorescence analysis to visualize GFP (green) 
or stained with rhodamine phalloidin to visualize Arf6:Q67L (red) and DAPI (blue) to visualize the 
nuclei. Scale bar: 20 µm. 
Lower panels: magnification of the selected area.  
B. Upper panels: confocal analysis of HeLa cells transfected with GFP-EFA6B and HA-Arf6:Q67L. 24 
hours after transfection, cells were fixed and processed for epifluorescence analysis to visualize GFP-
EFA6B (green) or stained with rhodamine phalloidin to visualize Arf6:Q67L (red) and DAPI (blue) to 
visualize the nuclei. Scale bar: 20 µm. 
Lower panels: magnification of the selected area.  
The enrichment of both NUMB and EFA6B in recycling compartments ARF6 positive 
prompted us to investigate if the activation of ARF6 favors their interaction. Co-IP 
experiments were performed on cell lysates transfected with active ARF6. We found that 
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the expression of ARF6 Q67L enhanced the interaction between NUMB and EFA6B (Fig. 
33). 
Figure 33. The interaction between NUMB and EFA6B is enhanced in the presence of ARF6.  
Left panel: NUMB-FLAG was immunoprecipitated with anti-FLAG M2 affinity gel (2 round with 30 
µl), using 3.0 mg of total cell lysate from Phoenix cells transfected with GFP-EFA6B and NUMB-
FLAG in the presence or not of HA-ARF6 QL. Immunoprecipitates were analyzed by WB analysis with 
the indicated antibodies. As a control, the same amount of both total cell lysates was immunoprecipited 
with anti MYC. MW markers are shown on the left of the blots. 
Right panel: quantification: relative Co-IP levels over the IP Flag. 
4.10 Removal of EFA6B and NUMB restores increased HGF-induced 
CDR formation induced by NUMB removal.  
Our results suggest that NUMB may regulate ARF6-dependent recycling by interacting 
and possibly by modulating its GEF EFA6B. If this scenario is true, the down-regulation of 
EFA6B should abrogate the increase of growth factors-induced CDRs due to NUMB 
ablation. To investigate our hypothesis, we performed EFA6B RNAi experiments in 
combination with NUMB RNAi. We found that removal of EFA6B by itself does not 
affect the formation of CDRs, while when combined ablation of EFA6B and NUMB is 
able to reduce the number of cells forming CDRs to control cell level (Fig. 34). These data 
suggest that the interaction between NUMB and EFA6B may regulate its GEF activity for 
ARF6. 
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Figure 34. Ablation of EFA6B and NUMB reduces increased HGF-induced CDR formation due to 
NUMB removal. 
A. HeLa cells transfected with siRNA against NUMB (N3, NN) or siRNA against EFA6B (si EFA6B 
#6) alone or in combination with siRNA against NUMB (si N3 si EFA6B #6 or si NN si EFA6B #6) or 
scramble oligo (si CTR, control) were seeded on matrigel-coated coverslips. After 48 hours, cells were 
serum starved (s) for 2 hours and stimulated with 100 ng/ml HGF for 4 minutes, fixed and stained with 
F-actin antibody. Scale bar 20 µm.  
B. Upper pannel. The number of cells forming CDR over the total number of cells per field was 
counted. At least 20 fields were analyzed in each condition and three independent experiment were 
performed. The data are presented as the mean ± SEM.  
Lower panel: Numb and EFA6B mRNA levels were analyzed by RT-PCR. The data are presented as 
the relative level of gene expression compared to control cells (si CTR).  
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5 DISCUSSION 
5.1 NUMB is a negative regulator of mesenchymal mode of motility. 
Single cells move in a 3D environment by exploiting two different modes of migration: a 
leucocyte-type ellipsoid “amoeboid” movement and a fibroblast-like spindle-shaped, 
“mesenchymal” migration(Friedl and Wolf 2003).  
The “amoeboid” mode of migration is characterized by less adhesive cell-matrix 
interaction and displays a diffuse structure of the actin cytoskeleton(Friedl, Borgmann, and 
Brocker 2001). This mode of migration is used by, for example, leucocytes and tumor cells 
of hematopoietic origin(Friedl, Borgmann, and Brocker 2001). The “amoeboid” 
designation is due to the ellipsoid morphology, the rapid cell shape and flexibility, which 
remind of the single-cell-state of the lower eukaryote Dictyostelium discoideum 
amoeba(Friedl, Borgmann, and Brocker 2001). Like in Dictyostelium discoideum, this type 
of movement does not require Matrix Metallo Proteases (MMPs) and integrins, whereas 
most cytoskeletal regulatory and adaptor proteins, including small GTPases, PIKs and 
actin-binding proteins, are necessary(Wolf, Muller, et al. 2003). Lymphomas, leukemia 
and small cell lung cancer, all of which are fast disseminating tumors, use a fast-gliding, 
propulsive migration mode independently of integrins, pericellular proteolysis, focal 
contact formation and stress fibers to rapidly disseminate within different tissues(Wolf, 
Muller, et al. 2003).   
Compared to the amoeboid mode of migration, mesenchymal mode of migration is strictly 
dependent on integrins and proteases that degrade the ECM(Friedl and Wolf 2003). This 
mode of migration is marked by tightly regulated focalized adhesion structures, protease 
activity and cytoskeletal contractility(Wolf, Mazo, et al. 2003; Davies et al. 2005). Thus, to 
migrate in a mesenchymal fashion, cells have to extend their polarized protrusions driven 
by a highly dynamic actin cytoskeleton, which is coupled to integrin clusters that serve as a 
transient clutch to grip onto the substrate, and to further acquire the ability to 
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proteolytically reorganize the ECM(Davies et al. 2005; Wolf, Mazo, et al. 2003). This 
mode of migration is typical of cells originating from connective tissue, sarcomas or 
dedifferentiated carcinomas(Davies et al. 2005; Wolf, Mazo, et al. 2003).  
The coordination of the intracellular trafficking of molecules, such as integrins and 
proteases, the adhesion to the substratum and the remodeling of the actin cytoskeleton to 
generate the propulsive forces are critical steps during mesenchymal, directed motility. 
Indeed, the crosstalk between endocytic/recycling compartments and the polarization of 
protease activity, adhesive molecules and cytoskeleton components is fundamental during 
mesenchymal migration to ensure spatial restriction of signaling.  Thus, in order to study 
the effect of endocytic/trafficking proteins on the mesenchymal mode of migration, an 
RNAi screening was set up and CDRs and PRs were used as readout markers. 
PRs are actin structures formed at the leading edge of the cells. PRs are active and 
persistent structures that form immediately upon growth factors stimulation(Suetsugu et al. 
2003). CDRs are actin-reach structures that are formed on the dorsal surfaces of motile 
cells(Suetsugu et al. 2003). These structures are dynamic and transient, and form upon 
stimulation with growth factors like EGF, HGF and PDGF(Buccione, Orth, and McNiven 
2004; Mellstrom, Heldin, and Westermark 1988; Orth and McNiven 2006). CDRs emerge, 
constrict and close, within 5 to 30 minutes after stimulation(Buccione, Orth, and McNiven 
2004). The PI3K and the small GTPase RAC are two major determinants in the signaling 
events downstream RTKs that drive CDR formation(Lanzetti et al. 2004). CDR formation 
has been involved in receptor internalization, macropinocytosis and mesenchymal 
migration(Hoon, Wong, and Koh 2012). As stated above, to migrate in a mesenchymal 
fashion, cells have to remodel the ECM. The matrix-degrading matrix metalloproteinase-2 
(MMP-2), WAVE 1, paxillin and Pyk2, all of which are important components of ECM, 
localize in CDRs(Buccione, Orth, and McNiven 2004; Suetsugu et al. 2003; Sero et al. 
2011). 
In our screening, we found that removal of the endocytic adaptor protein NUMB increased 
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CDR formation without affecting the formation of PR. Since NUMB is one of the main 
focuses of our research group, and little is known about the negative regulation of CDR 
formation, we set out to further characterize this novel and unexpected function of NUMB.  
The results of the screening were validated in two independent cell lines, HeLa and MEFs, 
stimulated with HGF and PDGF, respectively. Additionally, the expression of human GFP-
NUMB isoforms in MEFs interfered for endogenous, murine NUMB rescued the CDR 
phenotype, further proving that NUMB is a negative regulator of these migratory 
protrusions.  
The loss of NUMB not only increases the capacity of cells to form CDRs, but also 
enhances growth factor-mediated cell migration and invasion by promoting a mesenchymal 
mode of locomotion. Our findings are in line with data collected by Wang and colleges in 
MDCK cells(Wang et al. 2009).  In their work, they showed that, during EMT, NUMB 
functions as an endocytic adaptor protein for E-cadherin and regulates cell migration. They 
further demonstrated that upon HGF stimulation or Src activation, loss of NUMB caused 
basal-to-apico-lateral membrane translocation of E-cadherin and mislocalization of the 
Par-complex. These changes were mirrored by the finding that NUMB removal also 
promoted wound healing closure and chemotactic invasion: the former phenotype was 
rescued by re-expression of a siRNA-resistant NUMB version(Wang et al. 2009). NUMB-
deficient cells displayed also an increased proliferation, which, however, was shown not to 
account for the augmented cell migration(Wang et al. 2009). Molecularly, some of the 
NUMB-dependent changes were ascribed to its ability to modulate E-cadherin junctional 
stability. 
Additionally, NUMB, when phosphorylated by the aPKC polarity complex, has been 
reported to be required for integrin-dependent directional cell migration in HeLa 
cells(Nishimura and Kaibuchi 2007). At the leading edge, NUMB localizes to clathrin-
coated structures and binds to integrin-ßs, regulating their endocytosis(Nishimura and 
Kaibuchi 2007). Upon phosphorylation by aPKC, NUMB is released from clathrin-coated 
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structures and is not able to bind integrins(Nishimura and Kaibuchi 2007).  NUMB is also 
required for GCPs migration(Zhou et al. 2011). In this contest, it binds to activate BDNF 
receptor TrkB to control receptor endocytosis and recruits aPKC for activation. Active 
aPKC phosphorylates NUMB, enhancing the interaction between NUMB and TrkB to 
increase the formation of TrkB-NUMB endosomal complex(Zhou et al. 2011). Thus, the 
regulated interaction between the endocytic adaptor protein NUMB and the BDNF 
receptor TrkB is required to link the extracellular signal to the cellular polarity machinery, 
allowing directed migration in response to a BDNF gradient(Zhou et al. 2011).  
In all these studies(Wang et al. 2009; Nishimura and Kaibuchi 2007; Zhou et al. 2011), 
there is one common mechanism underlying NUMB function in cell migration: NUMB 
binds to RTKs and functions as a scaffold protein to recruit additional component, such as 
polarity complex or components of the endocytic machinery. NUMB, for example, could 
promote endocytosis and relocalization of the receptor to the front of the cells. The 
NUMB-receptor complex may remain in signaling endosomes within the leading process, 
and/or be recycled to the front of the cells to promote directional migration in response to 
receptor activation. 
5.2 NUMB is a negative regulator of the recycling compartment 
CDR formation has been shown to depend on the small GTPase RAB5(Palamidessi et al. 
2008). Indeed, upon motogenic stimuli, RAB5 promotes the accumulation of RAC1 to EE. 
In these organelles, RAC1 is activated by its GEF TIAM(Palamidessi et al. 2008). From 
the EE, active RAC1 is recycled back in an ARF6-dependent manner to specific regions of 
the PM, resulting in spatial restriction of RAC1 activity and the extension of polarized 
protrusions, such as CDRs(Palamidessi et al. 2008). We found that NUMB localizes in the 
two main compartments of this pathway: in EE induced by RAB5 expression and in 
enlarged endosomes induced by ARF6 dominant active expression. NUMB removal, 
however, does not impact on ARF6-independent recycling of EGFR and TfR (not shown), 
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but it specifically inhibits recycling of MHC class I and RAC1, which rely on ARF6. 
These findings are consistent with a scenario according to which a major functionally 
conserved role of NUMB is to act as a negative regulator of recycling both in invertebrates 
and in mammals. For example, in mammals, changes in NUMB expression alter NOTCH1 
trafficking(McGill et al. 2009). Indeed, using C2C12 cells, it was shown that NUMB 
overexpression promotes NOTCH translocation to late endosomes for degradation, 
whereas NUMB downregulation enhances NOTCH1 recycling(Bric et al. 2009). Although 
NOTCH recycling is not regulated by ARF6, this work suggests that NUMB is a negative 
regulator of this transport route(Bric et al. 2009). NUMB exerts negative regulation of the 
recycling route also in C. Elegans(Nilsson et al. 2008; Nilsson, Jonsson, and Tuck 2011) 
and in Drosophila(Cotton, Benhra, and Le Borgne 2013; Couturier, Mazouni, and 
Schweisguth 2013). In the nematode C. Elegans, overexpression of NUM-1A, the 
nematode NUMB homologue, causes similar defects to those caused by the loss of rme-1, 
the nematode homologue of EHD. These results indicate that NUM-1A negatively 
regulates recycling, a finding consistent with the fact that loss of NUM-1A bypasses the 
requirement for RME(Nilsson et al. 2008). The same groups also proposed that NUM-1A, 
in the recycling compartment, prevents the ability of TAT-1A to translocate 
phosphatidylserines across the membranes of recycling endosomes(Nilsson, Jonsson, and 
Tuck 2011). Two recent studies in Drosophila proposed that NUMB inhibits recycling of 
the Sanpodo-NOTCH complex back to the PM(Cotton, Benhra, and Le Borgne 2013; 
Couturier, Mazouni, and Schweisguth 2013). The authors suggested that the AP-2 and AP-
1-dependent trafficking, regulated by NUMB, is required for Sanpodo localization(Cotton, 
Benhra, and Le Borgne 2013; Couturier, Mazouni, and Schweisguth 2013). In fish, the 
OPO protein, a transmembrane protein similar to Sanpodo, antagonizes NUMB in the 
control of integrin trafficking, once again reinforcing the idea that NUMB negatively 
regulates post-internalization sorting events(Bogdanovic et al. 2012). 
Despite this wealth of concordant evidence, results from early studies in mammalian cells 
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suggested, instead, a positive role for NUMB in recycling(Smith et al. 2004). NUMB, via 
its NPF, was shown to interact in vivo and in vitro with EHD endocytic proteins. Of note, 
both NUMB and EHD proteins are localized to vesicles containing the small GTPase 
ARF6(Smith et al. 2004). The authors showed that the removal of NUMB inhibits the 
recycling of Tac receptors(Smith et al. 2004).  
Like the Tac receptor, also the MHC class I is internalized via CME and is recycled back 
via ARF6(Radhakrishna and Donaldson 1997). Our data support a scenario whereby 
NUMB removal increases the recycling of two ARF6 cargos, MHC class I and RAC. The 
differences between our results and those reported by McGlade’s laboratory may be due to 
the use of two different cell systems, to intrinsic limitations in the techniques used to test 
the recycling pathway, as well as to the reagent used to achieve NUMB removal. Indeed, 
rather than quantifying the amount of receptor on the PM, the authors monitored the 
amount of internalized receptor that decrease over time due to of recycling. They did not 
take into account the possibility that instead of being recycled, the internal pool of the 
receptor could be reduced due to degradation, especially in the absence of NUMB. The 
same experiment could be performed in the presence of an inhibitor of degradation to test 
this possibility.  
Nevertheless, other data present in the literature suggest a negative role for NUMB in 
recycling and support our findings. The underlying mechanisms, however, are still unclear. 
5.3 NUMB-EFA6B interaction and its biological implications.  
ARF6, like all GTPases, cycles between active and inactive conformation: a process tightly 
regulated by GEFs and GAPs, respectively(D'Souza-Schorey and Chavrier 2006). Three 
obvious, but distinct molecular mechanisms that directly impinge on ARF6 activity can be 
hypothesized to account for how NUMB acts as a negative regulator of the recycling 
pathway: i) NUMB can inhibit a GEF; or ii) activate a GAP, or iii) modulate the binding or 
activity of ARF6 downstream effectors.  
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Since the most common mechanism of regulation of small GTPases relies on GEFs, we 
initially tested the first hypothesis. We found that among the GEFs for ARF6, EFA6B 
directly interacts with NUMB via its PTB domain. We have also discovered that the N-
terminal region of EFA6B contains an NPxF consensus binding site for the PTB domain of 
NUMB(Zwahlen et al. 2000), and showed that this motif is required for the interaction 
with NUMB. Notably, the N-terminal of EFA6B appears to be the major determinant of 
the interaction with NUMB. However, also the region encompassing the entire PH and C-
terminal portion (739-1056) of EFA6B binds to NUMB, albeit weakly.  
The expression of EFA6 in cells is able to induce ruffles and microvilli-like 
protrusions(Derrien et al. 2002; Franco et al. 1999). It has been demonstrated that the 
conserved C-terminal regions of EFA6A and EFA6B are able to induce morphological 
changes in the PM due to their ability to bind to F-actin(Derrien et al. 2002; Franco et al. 
1999). In our work, we unveiled a novel function for the EFA6B N-terminal portion, 
whose functional role has long remained ill-defined. We have shown that mutations in the 
NPxF motif strongly reduce the binding with NUMB and abolish the binding to the PTB 
domain. Recently, while our study was being carried out, Okada and colleagues found that 
the N-terminal of EFA6B contains a binding site for dynamin2 that is required for the 
proper activation of ARF6 by the latter(Okada et al. 2015). Notably, this interaction site is 
located upstream of the NPxF motif, suggesting the possibility that EFA6B may 
concomitantly interact with dynamin2 and NUMB and that this complex may serve as a 
regulatory machinery of the docking site for the recruitment and/or activation of ARF6 at 
the early stage of internalization. The recent observations that ARF6 is transiently recruited 
at sites of clathrin coat formation, but that perturbations of its activity do not affect the rate 
of internalization, support the possibility that this GTPase may indeed be recruited along 
the endocytic machinery to be functionally operative at later steps of trafficking. 
Consistently, ARF6 silencing was shown to alter recycling but not internalization of 
TfR(Montagnac et al. 2011). 
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Our data are consistent with the possibility that NUMB, by physically interacting with 
EFA6B, may modulate ARF6 activation. If our hypothesis is correct, NUMB removal 
should affect the levels of ARF6 activation and its function should strictly depend on 
EFA6B. The latter possibility is supported by the finding that the increased number of 
CDRs caused by NUMB silencing is completely abrogated by concomitant loss of EFA6B. 
Of note, EFA6B by itself does not affect CDR formation induced by growth factors, 
suggesting that others GEFs, which are not targeted by NUMB, might be involved in this 
pathway and that only in the absence of NUMB the NUMB-EFA6 axis may become 
prominent. Further experiments are required to confirm the NUMB-EFA6B genetic 
interaction. It will be indeed interesting to investigate the effect of the double RNAi on 
MHC class I or RAC recycling. 
Whether by interacting with EFA6B NUMB impacts on its GEF activity and alters ARF6-
GTP levels remains still an open issue. We are currently setting up an in vitro GEF 
assay(Derrien et al. 2002; Padovani et al. 2014) using the battery of recombinant purified 
wild type and mutant proteins described in the result section. We are also setting up pull 
down assays with GST-GGA3, a protein that recognizes ARF6-GTP specifically, in order 
to monitor ARF6-GTP levels in cells. We managed to find the proper experimental 
conditions to detect reliable ARF6-GTP levels in the presence of EFA6B in 293T cell. If 
NUMB alters EFA6B ARF6-GEF activity, we will also verify whether EFA6B (or its 
mutant in the NPxF) ectopic expression could rescue the increased capacity of NUMB-
depleted cells to form CDRs in conditions in which both endogenous NUMB and EFA6B 
are knocked down. The same type of experiments will be performed to assess cell 
migration and invasion.  
5.4 NUMB biochemical implications on ARF6 activity. 
In our model, we hypothesized that in unperturbed conditions, NUMB binds EFA6B and 
controls ARF6 activation. Indeed, in the absence of NUMB there is an increase in CDR 
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formation and in ARF6 recycling, which may be due to the ability of free EFA6B to 
activate ARF6. If our hypothesis is correct, this should correlate with increased ARF6-GTP 
levels upon NUMB removal and concomitant stimulation with a growth factor. On the 
other hand, ectopic expression of NUMB in combination with EFA6B should decrease 
ARF6-GTP levels.  
If, by chance, the experiments will not confirm our model, different molecular mechanisms 
will be explored to elucidate the NUMB-EFA6B interaction. 
5.4.1 Altered localization of key determinants. 
Rather than by interfering with the EFA6B GEF activity, NUMB may alter EFA6B and 
ARF6 localization, ultimately deregulating their function. We have already shown that 
both EFA6B and NUMB are localized to the PM and in enlarged endosomes induced by 
ARF6 active mutants, but more localization studies are required to fully address this issue. 
For example, we will study EFA6B localization in cells that express NUMB or in cells in 
which the expression of NUMB has been silenced, and look for possible links with the 
ARF6 compartment.  
5.4.2 Impacts on the internalization of selected molecules. 
Another possibility is to investigate whether the EFA6B-NUMB interaction alters the 
internalization step of selected cargos. It has been reported that the expression of EFA6A 
inhibits TfR uptake and causes redistribution of the TfR to the PM, albeit the mechanisms 
through which this occurs remains unclear(Franco et al. 1999). The expression of 
endophilin, a key regulator of CME, was shown to rescue EFA6A-induced inhibition of 
TfR internalization due to an interaction between the SEC7 domain of EFA6A and the N-
BAR domain of endophilin on flat membranes(Boulakirba et al. 2014). Moreover, in the 
presence of EFA6A, endophilin is redistributed from the cytosol to the PM(Boulakirba et 
al. 2014). A similar scenario may also be at play in the case of NUMB and EFA6B.  We 
should, however, first prove that, like EFA6A, EFA6B inhibits TfR uptake. Nevertheless, 
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it will be worth investigating NUMB function in the same context considering the fact that 
its role regarding TfR trafficking is still not clear(Teckchandani et al. 2009; Sorensen and 
Conner 2008) and data collected in our laboratory suggest that NUMB is not required for 
TfR recycling.  
A novel mechanism of ARF6 activation has been recently reported. EFA6B, by interacting 
with dynamin2, was shown to activate ARF6(Okada et al. 2015). The evidence in support 
of the mechanism of action has been largely obtained through biochemical approaches; 
indeed, both a GTPase-deficient mutant of dynamin2 and a dominant negative mutant of 
EFA6B were shown to significantly inhibit dynamin2-induced ARF6 activation(Okada et 
al. 2015). In addition, the expression of the minimal fragment of EFA6B required for 
dynamin2 interaction was demonstrated to decreases TfR internalization(Okada et al. 
2015). This set of findings suggests the possibility that by interacting with EFA6B, NUMB 
may impinge on dynamin2-mediated ARF6 activation. 
5.4.3 Subversion of trafficking routes. 
In the case of the ß2 adrenergic receptor, ARF6 is activated by EFA6A in a ß-arrestin-
dependent manner. The activation of ARF6 does not impact on the internalization rate of 
the receptor but blocks its RAB4-dependent fast recycling. Prolonged activation of ARF6 
induces translocation of the ß2 adrenergic receptor in late endosomes, thus leading to 
desensitization and downregulation of signaling. It can be possible to speculate that upon 
stimulation of RTKs with their cognate ligands, ARF6 is activated by EFA6B and that in 
the presence of EFA6B the fast recycling route could be blocked, leading to receptor 
degradation. If NUMB expression sequesters EFA6B and prevents ARF6-activation, the 
fast recycling route should be active. Thus, another mechanism by which NUMB could 
affect endocytic pathways might be the subversion of trafficking routes.  
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5.5 NUMB-EFA6B-ARF6 axis in cancer and stem cells 
Loss of NUMB occurs in 50% of breast cancer(Pece et al. 2004) and in 30% of lung 
cancer(Westhoff et al. 2009), and correlates with an increased aggressiveness and poor 
prognosis of these tumors. Although some of the underlying molecular mechanisms have 
been elucidated(Pece et al. 2004; Colaluca et al. 2008; Westhoff et al. 2009; Pece et al. 
2011) (loss of NUMB was shown to lead to decreased p53 levels and increased NOTCH 
activity), our data highlight a new potential mode of action of NUMB that may also 
function in the spatial restriction of signaling that controls cell migration and invasion. Our 
model suggests that NUMB acts downstream of growth factor-activated receptors and may 
control ARF6-dependent recycling by binding EFA6B. ARF6 and EFA6B have been 
reported to be involved in breast cancer progression and invasion(Schweitzer, Sedgwick, 
and D'Souza-Schorey 2011; Zangari et al. 2014; Hashimoto et al. 2016; Hashimoto et al. 
2004; Marchesin et al. 2015). Since loss of NUMB correlate with an increased 
aggressiveness and poor prognosis(Pece et al. 2004) in breast cancer, we will investigate: 
1) EFA6B levels and ARF6 GTP status in NUMB positive vs. negative tumors and in 
breast cancer primary cell lines derived from NUMB-proficient and NUMB-
deficient tumors. This approach will allow us to understand if NUMB, EFA6B and 
ARF6-GTP expression levels correlate with tumor progression and aggressiveness. 
2) Cell migration and invasion assays in different NUMB-proficient and NUMB-
deficient breast cancer-derived primary cell lines. NUMB levels will be restored in 
NUMB-deficient cells by inhibition of proteasomal degradation(Pece et al. 2004) or 
expression of exogenous NUMB. The expression of NUMB will also be knocked-
down in primary NUMB-proficient breast cancer cell lines to investigate whether it 
will affect migration and invasion. 
In the contest of the mammary gland, loss of NUMB contributes to tumorigenesis by 
promoting the expansion of the stem cell pool and driving progenitor maturation through 
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EMT(Tosoni et al. 2015). These phenotypes depend on the control of NUMB over p53 
stability(Tosoni et al. 2015). We are currently characterizing a novel function of NUMB in 
the regulation of spatial restriction of signaling, which is related to the interaction with the 
EFA6B-ARF6 pathway. Since little is known about the role of ARF6 and the control of 
trafficking pathways in stem or progenitor cells of the mammary gland, it would be 
interesting to investigate whether the removal ARF6 and EFA6 impinge on the tumor 
suppressor role of NUMB in this setting. 
5.6 Concluding remarks 
NUMB is an endocytic protein with tumor suppressor functions. As a tumor suppressor, 
NUMB is downregulated in several types of cancer, such as breast, lung, salivary gland 
and liver tumors. The mechanism leading to its downregulation in breast and lung tumors 
is massive ubiquitination and, as a consequence, proteasomal degradation.  Loss of NUMB 
in these tumors correlates with increased p53 degradation and NOTCH hyper-activation. 
As an endocytic adaptor, NUMB controls different trafficking routes, such as endocytosis 
and degradation, and controls different signaling pathways. NUMB regulates also cell 
migration, cell adhesion and EMT. 
In this present study, we have shown that, in cancer cell, NUMB is a negative regulator of 
spatially defined protrusions, cell migration and invasion.  
Molecularly, these phenotypes merge with the nascent scenario in which NUMB is 
appearing as a negative regulator of recycling pathways even if little is known about the 
underlying molecular mechanism. Indeed, we found that NUMB is a negative regulator of 
MHC class I and RAC recycling, both of which depend on ARF6. Data collected in this 
study suggest that NUMB might regulate ARF6 by modulating its GEF, EFA6B. We have 
shown that the NUMB PTB domain interacts with the N-terminal region of EFA6B, which 
contains an NPxF motif. Lastly, we will assess whether NUMB affects ARF6 activation by 
modulating EFA6B GEF activity. 
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The novel molecular mechanism that we are characterizing has different potential 
applications. We will investigate ARF6 and EFA6B status in NUMB-deficient cancer cells 
in the context of the stem cell niche. These investigations should open new avenues in the 
development of novel therapies for NUMB-deficient cancers. 
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6 MATERIALS AND METHODS 
6.1 Common laboratory Solutions 
6.1.1 Phosphate-buffered saline (PBS) 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
2 mM KH2PO4 
The solution is prepared by dissolving 8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, and 
0.24 g of KH2PO4 in 800 mL of distilled water. The pH is adjusted to 7.4 with HCl and 
distilled H2O is added to 1 litre. 
6.1.2 Tris HCl (1 M) 
Prepared by dissolving 121.1 g of Tris base in 800 mL distilled H2O. The pH is adjusted 
(depending on the case) with HCl, and distilled H2O is added to 1 litre.  
6.1.3 10X Tris EDTA (pH 7.4-8.0)  
 100 mM Tris HCl (pH 7.4-8.0) 
 10 mM  EDTA (pH 8.0) 
6.1.4 50x TAE (Tris-Acetate-EDTA) 
 242 g/L      Tris base  
57.1 mL/L      Acetic acid  
20 mL/L       0.5 M EDTA pH 8  
The pH is adjusted to 8.5 with HCl and distilled H2O is added to 1 litre. 
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6.1.5 Tris-buffered saline (TBS) 
It is prepared by dissolving 8 g of NaCl, 0.2 g of KCl, and 3 g of Tris base in 800 mL of 
distilled H2O. The pH is adjusted to 7.4 with HCl and distilled H2O is added to 1 litre final 
volume. 
6.1.6 1.4x JS lysis buffer 
50 mM HEPES PH 7.5 
50 mM NaCl 
 1% glycerol 
 1% Triton X-100 
 1.5 mM MgCl2 
 5 mM EGTA 
To this solution phosphatases and proteases inhibitors were freshly added: 
 protease inhibitor cocktail (Roche, Basel, Switzerland) 
1 mM DTT 
20 mM Na pyrophosphate pH 7.5 
 50 mM NaF 
 0.5 M Na-vanadate in HEPES pH 7.5  
6.1.7 5x (2x) SDS-PAGE Sample Buffer 
10% (4%) SDS 
500 mM (200mM) Tris pH 6.8 
30% (12%) glycerol 
0.03% (0.0012%) saturated bromophenol blue 
15% (6%) (v/v) β-mercaptoethanol (14M) 
Stored at 4°C, protected from light by foil. 
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6.1.8 10x SDS-PAGE Running Buffer  
144 g/L Glycine 
30 g/L Tris base 
1% SDS 
6.1.9 10x Western Transfer Buffer  
144 g/L Glycine 
30 g/L Tris base 
Diluted at 1x concentration in 20% of MeOH. 
 
6.1.10 Ponceau S 
 0.1% (w/v) Ponceau (C22H12N4Na4O13S4) (Sigma) 
5% Acetic acid 
6.2 Basic cloning techniques 
6.2.1 Agarose gel electrophoresis 
DNA samples were loaded on 0.8%-2% agarose gels along with DNA markers. Gels were 
made in TAE buffer containing 0.3 µg/mL ethidium bromide and run at 80V until desired 
separation was achieved. DNA bands were visualized under a UV lamp. 
6.2.2 Minipreps 
E.coli Top10 Cells (Invitrogen) picked from individual transformed colonies were used to 
inoculate 3 mL LB (containing the appropriate antibiotic) and grown overnight at 37°C in 
15mL Falcon tubes. Cells were pelleted for 15 minutes at 2500 rpm. Minipreps were 
performed according to the manual instructions (Promega, Wizard Plus SV Minipreps). 
The final elution was made in 80µl of milli-Q water. DNA was checked performing an 
agarose gel electrophoresis using 5µl of the elution. 
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6.2.3 DNA digestion 
Between 0.5 and 2 µg DNA was digested for 2 hours at 37°C with 10 units of restriction 
enzyme (NEB). For digestion, the volume was readjusted to 10 µl with the appropriate 
buffer and ddH2O (20µl in case of double digestions). 
6.2.4 Large Scale Plasmid Preparation 
E.coli Top10 Cells (Invitrogen) containing the desired DNA vector were expanded into 
500 mL cultures overnight with the appropriate antibiotics. Plasmid DNA was isolated 
from these cells using the Qiagen Maxi-prep kit (Qiagen,Valencia, CA) according to the 
manufacturer’s instructions. 
6.2.5 Transformation of competent cells 
E.coli Top10 cells (Invitrogen) were used for cloning and large scale DNA preparation, 
while E.coli BL21 Rosetta (DE3) cells (Promega) were used for proteins production. The 
transformation protocol used was the same for both strains. 
50 µl of fresh competent cells, one shot TOP10 (Invitrogen), were thawed on ice for 
approximately 10 minutes prior to the addition of plasmid DNA. Cells were incubated with 
DNA on ice for 20 minutes and then subjected to a heat shock for 45 seconds at 42°C. 
Cells were then returned to ice for 2 minutes. Then, 0.250 mL of LB were added and the 
cells were left at 37°C for 60 minutes (with 200 rpm shaking) before plating them onto 
plates with the appropriate antibiotic. 50 µl of the transformed bacterial were usually 
plated. Plates were incubated overnight at 37°C. 
6.2.6 DNA elution from agarose gel 
DNA elution from agarose gel was performed using the Wizard SV Gel and PCR Clean-
Up System (Promega), following manufacturer’s instructions. 
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6.2.7 PCR (Polymerase Chain Reaction) 
Sense and antisense oligos, of 20-30 nucleotides each, were generated, one annealing in 5’ 
(forward) and the other in 3’ (reverse) to the target sequence. The primers were designed of 
similar length and annealing temperature. Melting temperature of the primers was 
calculated according to the formula: Tm = 81.5+0.41(%GC) - 675\N - % mismatch. These 
primers were used in a PCR reaction together with the DNA template and the Phusion 
High-Fidelity DNA Polymerase (NEB).  
Reaction mixture 
5x Phusion GC buffer            10 µl 
DNA template  10-20 ng 
primer forward   0.5 µM 
primer reverse  0.5 µM 
dNTPs mix   0.2 mM 
Pfu (Promega)  1 U 
ddH2O     to a final volume of 50 µl 
There are three major steps in a PCR (denaturation, annealing and extension), which were 
repeated for 25 cycles. This was done on an automated cycler (GeneAmp PCR system 
9700, Applied Biosystems), which can heat and cool the tubes with the reaction mixture in 
a very short time. 
Cycling parameters:     
Step Temperature   Time            N° of cycles 
A) denaturation at 98°C   30 seconds            1 
B) denaturation at 98°C   10 seconds             25 
 annealing at X°C  30 seconds   
 extension at 72°C   (30 seconds/each kb of target length) 
C) extension at 72°C  10 minutes     1 
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6.2.8 Generation of EFA6B deletion constructs 
EFA6B deletion constructs were obtained through PCR, using as template the pEGFP_C3 
vector containing the cDNA sequence of human EFA6B. To clone the different constructs 
specific primers were designed flanked by Bgl II and Sal I sites. DNA fragments were then 
subcloned either in an empty pGEFP_C1 vector after Bgl II-Sal I double digestion, or in an 
empty pGEX6p1 vector BamH I-Sal I double digestion or in an empty pBAC_His-MBP-
TEV vector BamH I-Sal I double digestion and subsequent ligation. 
 
USED PRIMERS: 
Constructs Primers 
1-554 aa 
Fwd: 5’ cgagatctatgggtgactacagactccctg 3’ (Tm=59°C) 
Rew: 5’ gtcgacttaccaagaagagttcatcggtgt 3’ (Tm=56°C) 
555-1056 aa 
Fwd: 5’ cgagatctcttcctgggagccctatg 3’  (Tm=57°C) 
Rew: 5’ cggtcgactcacagctgattgcggtt 3’  (Tm=56°C) 
1-738 aa 
Fwd: 5’ cgagatctatgggtgactacagactccctg 3’  (Tm=59°C) 
Rew: 5’ gtcgacttagagcttctcgctgcggat 3’  (Tm=58°C) 
739-1056 aa 
Fwd: 5’ cgagatctgagtgggccgtggatgaa 3’  (Tm=58°C) 
Rew: 5’ cggtcgactcacagctgattgcggtt 3’  (Tm=56°C) 
555-738 aa 
Fwd: 5’ ggatccgtgatcaatatcacttatgactcc 3’ (Tm=58.5°C) 
Rew: 5’ cgagatctcttcctgggagccctatg 3’  (Tm=57°C) 
1-256 aa Fwd: 5’ cgagatctatgggtgactacagactccctg 3’ (Tm=59°C) 
 Rew: 5’cggtcgacttaaggactcgccaggaagagg3’ (Tm=59°C) 
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256-554 aa Fwd: 5’ cgagatctccttgctcagagaacagt 3’ (Tm=52°C) 
 Rew: 5’ gtcgacttaccaagaagagttcatcggtgt 3’ (Tm=56°C) 
EFA6 B Fwd: 5’ cgagatctatgggtgactacagactccctg 3’ (Tm=59°C) 
 Rew: 5’ cggtcgactcacagctgattgcggtt 3’  (Tm=56°C) 
6.2.9 Site directed mutagenesis 
Site directed mutagenesis was performed using the Quick Change mutagenesis kit 
(Stratagene), following manufacturer’s instructions. Briefly, a sense and an antisense oligo 
of about 30-45 nucleotides each, carrying the desired mutation in the middle of the 
sequence, were generated and used in a PCR reaction using the wild type construct (100-
300 ng) as template. PCR was performed using the Phusion High-Fidelity DNA 
Polymerase (NEB) for 16 cycles.  
For the amplification step, 16 PCR cycles were performed with a denaturation step of 30 
seconds at 95ºC followed by an annealing step of 1 minute at 55ºC and an extension step at 
72ºC of 1 minutes/each kb of plasmid length. 
After amplification, 1 µl of DpnI restriction enzyme, which selectively cuts methylated 
DNA at the GATC sequence, was added to digest the wild-type parental DNA. After one-
hour incubation at 37˚C, the PCR product was used to transform competent E. coli Top10 
cells (Invitrogen) and single colonies were sequenced for the presence of the desired 
mutation and the absence of other, unwanted, base changes. The presence of the desired 
DNA amplification was also checked by DNA electrophoresis of 10µl of the product in a 
1-2 % agarose gel. 
6.2.10 Generation of EFA6B point mutants 
The different EFA6 B mutants were generated performing site directed mutagenesis using 
the Quick Change mutagenesis kit (Stratagene), following manufacturer’s instructions (see 
also section 7.3.8). Specific primers were designed: 
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Constructs Primers 
1-554 aa N248A 
Fwd: 5’ atgttcttcagcgcccccctcttcc 3’  
Rew: 5’ ggaagaggggggcgctgaagaacat 3’  
1-554 aa F251A 
Fwd: 5’ atgttcttcagcaaccccctcgccctggcgagtcctt 3’  
Rew: 5’ aaggactcgccagggcgagggggttgctgaagaacat 3’  
 
The pGEX EFA6B 1-554 aa N248A, F251A, the pGEX EFA6B 1-739 aa N248A, F251A 
and the pBAC EFA6B N248A, F251A were generated by GenScript company. Then the 
EFA6B 1-554 aa N248A, F251A fragment and the EFA6B N248A, F251A were amplified 
by PCR reaction with primers flanked by Bgl II and Sal I sites. DNA fragments were then 
subcloned in an empty pGEFP_C1 vector after Bgl II-Sal I double digestion and 
subsequent ligation. 
6.3 Antibodies, plasmid and reagents 
The antibodies used were: anti-NUMB (Pece et al. 2004); anti-vinculin (Sigma), anti-GFP 
(gift from Jan Faix (Hannover)); anti-FLAG (Sigma); anti RAB5A (Santa Cruz 
Biotechnology); anti HA (Santa Cruz Biotechnology); anti EEA1 (Santa Cruz 
Biotechnology); anti MHC class I (Santa Cruz Biotechnology). 
GFP NUMB isoforms, NUMB FLAG, GST NUMB fusion proteins, NUMB His and 
NUMB PTB His were a gift from I. Colaluca. pEGFC3 EFA6B, pEGFPC3 EFA6A and 
pEYFP ARNO were a gift from P. Chavrier. pCMV RAB5A, paGFP-RAC and pCDNA 
ARF6 QL were described previously in Palamidessi et al, 2008. pBAC_His-MBP-TEV 
vector was a gift from S. Pasqualato. pEGFPC1 EFA6B deletion mutants and MBP-
EFA6B were obtained by PCR reaction.  
Recombinant Human HGF (used at 100 ng/mL) was from R&D Systems. Recombinant 
Human Platelet Derived Growth Factor-BB (PDGF-BB, used at 1 ng/mL) was from 
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Immunological Sciences. 
6.4 Cell culture 
6.4.1 Cells culture 
HeLa cells were grown in Minimum Essential Medium (MEM Invitrogen) supplemented 
with 10% South American serum (EuroClone), 1% non essential ammino acids and 1% 
Sodium Pyruvate. Immortalized mouse embryo fibroblasts [MEFs, (Scita et al., 1999)] 
were grown in Dulbecco's Modified Eagle Medium (DMEM, Lonza) supplemented with 
10% South American serum (EuroClone) and 1% L-Glutamine (EuroClone). Phoenix cells 
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Lonza) supplemented with 
South American serum (EuroClone) and 1% L-Glutamine (EuroClone). Cells were grown 
at 37°C in 10% CO2. 
6.4.2 Transfection  
Transfections were performed using the calcium phosphate method, electroporation or 
Lipofectamine (Invitrogen). 
Phoenix cells were transfected using the calcium phosphate procedure. In this case DNA 
(20 µg for a 15 cm plate) was diluted in 878 µl of ddH2O and 122 µl of 2M CaCl2 were 
added. This solution was added, drop-wise, to 1 mL of HBS 2x. Then, the precipitate was 
added to the cells (plated on 15 cm dishes) and removed after 12-16 hours.  
Electroporation was used to transfect MEF cells for CDR rescue experiment, using the 
MicroPorator system (Digital Bio Technology) according to manufacturer’s instructions. 
Cells were microporated with one pulse of 20 ms at 1650 V, with a cell density of 5*106 
cells. 
Lipofectmane (Invitrogen), according to manufacturer’s instruction, was used to transfect 
HeLa cells for IF experiments.  
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2x HBS pH 7.5 
50 mM Hepes pH 7.5 
10 mM KCl 
12 mM dextrose 
280 mM NaCl 
1.5 mM Na2HPO4  
6.4.3 Short interfering RNA (siRNA) experiments 
siRNAs (small interfering RNAs) delivery was achieved by mixing from 5 to 50 nM of 
specific siRNAs with Optimem and Lipofectamine RNAiMAX Transfection Reagent (Life 
Technologies) by two cycles of transfection according to manufacturer’s instruction. For 
each RNA interference experiment, negative control was performed with the same amount 
of scrambled siRNAs (si CTR). Knocking down efficiency was controlled by western blot 
or qRT-PCR. 
Four different siRNAs were used for hNUMB KD, three different siRNAs were used for 
mNUMB KD and two different siRNAs were used for EFA6B KD, with comparable 
results.  
Oligos details as follows: 
hNUMB oligo N3: TACACACCTCTTCTAACCATCGGTC (Invitrogen, Inc);  
hNUMB oligo NN: GGACCTCATAGTTGACCAGTT (NUMB Nishimura, Thermo); 
hNUMB oligo #5: AAATGTAGCTTCCCGGTTA (ON-TARGETplus NUMB siRNA J-
015902-05, Dharmacon);  
hNUMB oligo #6: TAAGATAGTCGTTGGTTCA (ON-TARGETplus NUMB siRNA J-
015902-06, Dharmacon); 
mNUMB oligo #2: AGAAAGAAAGACCTTT (Riboox);  
mNUMB oligo #3: CGGGAAAGAAAGCAG (Riboox); 
mNUMB oligo #4: ATCTGTCATTGTTTC (Riboox); 
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EFA6B #6: GAACCGCAATCAGCTGTGA (ON-TARGETplus PSD4 siRNA J-019959-
06, Thermo); 
EFA6B #7: GCAATCATGCTGCTTAACA (ON-TARGETplus PSD4 siRNA J-019959-
07, Thermo). 
si CTR: TCGAATACGAACATTTATTT (Thermo) 
6.4.4 Total RNA extraction and reverse transcription 
Total RNA was extracted using RNeasy Mini kit (Qiagen) and quantified by NanoDrop to 
assess both concentration and quality of the samples. Reverse transcription was performed 
using SuperScript VILO cDNA Synthesis kit from Invitrogen and gene expression was 
analyzed using TaqMan Gene expression Assay (Applied Biosystems). GAPDH was used 
as normalizer. 
6.4.5 Quantitative RT-PCR detection of mRNAs 
Gene expression was analysed using TaqMan Gene expression Assay (Applied 
Biosystems). More in details, 0.1 ng cDNA was amplified, in triplicate, in a reaction 
volume of 25 µl with 10 pMol of each gene-specific primer and the SYBR-green PCR 
MasterMix (Applied Biosystems). Real-time PCR was performed on the 14 ABI/Prism 
7700 Sequence Detector System (PerkinElmer/Applied Biosystems), using a pre-PCR step 
of 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. Specificity of 
the amplified products was confirmed by melting curve analysis (Dissociation Curve TM; 
PerkinElmer/Applied Biosystems) and by 6% PAGE. Samples were amplified with 
primers for each gene (listed in the table below) The Ct values were normalized to the 
GAPDH curve. Results were quantified using the 2-∆∆CT
 
method. PCR experiments were 
performed in triplicate. 
Gene name Primer assay ID 
GADPH Hs99999905_m1 
Mm99999915_g1 
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EFA6A Hs00160539_m1 
Mm01194193_m1 
EFA6C Hs00260268_m1 
Mm01158081_m1 
EFA6D Hs00209633_m1 
Mm01351099_m1 
EFA6B Hs00202892_m1  
Mm00617130_m1 
Cytohesin 1 Hs00245092_m1 
Mm01248760_m1 
Cytohesin 2 Hs00244669_m1 
Mm01194052_g1 
Cytohesin 3 Hs01028931_m1 
Mm01201634_m1 
6.4.6 Cell lysis  
After washing with PBS 1x, cells were lysed in JS buffer directly on the plates using a cell-
scraper. About 200 µl of JS buffer/10 cm plates were used. Lysates were incubated on ice 
for 10 minutes and spun at 13200 rpm for 10 min at 4ºC. The surnatant was transferred into 
a new eppendorf and protein concentration was measured by the Bradford assay (Biorad), 
following manufactur’s instructions. 
6.5  Imaging techniques 
6.5.1 Immunofluorescence 
Cells were plated on glass coverslips (pre-incubated with 0.5% gelatin in PBS at 37˚C for 
30 minutes in the case of MEFs). After 24 h, cells were processed for epifluorescence or 
indirect immunofluorescence microscopy. Cells were fixed in 4% paraformaldehyde for 
10’, washed with PBS and permeabilized in PBS 0,1% Triton X-100 for 10 minutes at 
room temperature (RT). To prevent non-specific binding of the antibodies, cells were then 
incubated with PBS in the presence of 1 % BSA for 10 minutes. 
The coverslips were then gently deposited, face down, on 50 µl of primary antibody 
diluted in PBS 1% BSA, spotted on Parafilm. After 40 minutes of incubation at RT, 
coverslips were transferred into 12 well plates and washed three times with PBS. Cells 
were then incubated for 40 minutes at RT with the appropriate secondary antibody. F-actin 
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was detected by staining with Alexa 488 or Alexa 594-conjugated phalloidin (Molecular 
Probes) at a concentration of 6.7 U/mL. 
After three washes in PBS, coverslips were transferred into 12 well plates and incubated in 
PBS containing DAPI (1:3000) for 5 minutes at RT. Coverslips were washed three times in 
PBS coverslips and mounted in mowiol (20% Mowiol (Sigma), 5% Glycerol, 2.5% 
DABCO (Molecular Probes), 0.02% NaN3 in PBS) and examined by fluorescent optical 
microscopy or in a 90% glycerol solution containing diazabicyclo-(2.2.2)octane antifade 
(Sigma) and examined under a Biorad MRC 1024 confocal microscope equipped with a 20 
mW Kr-Ar laser for colocalization analysis. Confocal image acquisition was performed in 
sequential mode to limit channel cross-talk and corrected for residual fluorescence bleed 
through. Green fluorescence was collected through a 520±35 nm band-pass filter, while the 
red channel filter was a 605±20 nm band-pass. Images were further processed with the 
Image J software (Adobe). 
For two-photon fluorescence microscopy, a Chameleon-XR (Coherent) Ti:sapphire laser 
source was directly coupled to the scanning head of a Leica TCS SP5 AOBS confocal 
microscope using an infrared port. Two-photon activation was performed by irradiating a 
specific vesicle at λ = 790 nm with a pixel dwell time of 4.9 µs and an activation average 
power < p > = 10 mW. The targeted region was subjected to pulses of high-energy-density 
infrared light (λ = 790 nm) to induce photoactivation. Each pulse had a 1 s duration, and a 
time interval of 20 s between pulses was set to avoid photobleaching of the activated 
molecules. Imaging of the activated proteins was obtained using the 488 nm line of a 20 
mW Argon ion laser using a 100× oil N.A. = 1.4 objective HCX PL APO (Leica 
Microsystems). The spectral window used for collecting fluorescence was 500–600 nm 
6.5.2 Si RNA- based screening 
A candidate siRNA-based screening was performed to identify endocytic molecules 
specifically required for the formation of HGF- induced circular dorsal ruffles (CDRs) or 
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peripheral ruffles. HeLa cells were transfected with scrambled control (si CTR) or the 
indicated specific siRNA and stimulated with HGF (100 ng/mL) and/or EGF (100 ng/mL) 
for 10 min before fixing and staining with phalloidin. The identification of F-actin–positive 
apical CDRs and Peripheral ruffles was facilitated by 3D reconstruction of confocal serial 
z sections. The fraction of siRNA-treated HeLa cells forming CDR or PR structures 
relative to that of control, HGF-stimulated cells was calculated. Three independent 
experiments were performed and 40 cells/experiment were analyzed. 
6.5.3 CDR formation assay 
To evaluate CDR formation HeLa cells were seed on matrigel coated coverslips. To 
perform the coating, matrigel was diluted at 0.5 mg/mL in cold 50% DMEM/F12 (without 
serum) on ice. Then a refrigerated 6-well plate with coverslips placed was putted on ice 
and 1mL of solution was added and homogeneously distributed. Then the plate was 
incubated 1h at RT. After two washes with PBS, 75.000-100.000 HeLa cells were seed for 
48h until to perform the serum starvation and the HGF stimulation. 
6.5.4 Single cell migration assay 
Single cells migration was monitored as followed. Briefly, si CTR and si NUMB HeLa 
cells, upon 24h of interference, were seeded sparsely in a 6-well plate (2*104
 
cells/well) in 
complete medium. After 24h cells were serum starved for 2h and stimulated with 100 
ng/mL HGF. Random cell motility was monitored over a 19 hours period. Pictures were 
taken every 5 minutes from 10 positions/condition, using a motorized Olympus Scan^R 
inverted microscope with 40X objective. All the experiments were performed using an 
environmental microscope incubator set to 37°C and 5% CO2 perfusion. Single cells were 
manually tracked using Manual Tracking Tool ImageJ software plugin. Elongation Index 
was calculated as the ratio between the major and the minor axis. Distance and velocity 
were obtained by Chemotaxis and Migration Tool ImageJ software plugin. 
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6.5.5 Invasion assay 
Cell invasion assays were performed using a BD BioCoat GFR Matrigel Invasion Chamber 
(BD Biosciences) composed of a polycarbonate membrane, containing 8 µm pores, 
covered with a thin layer of GFR Matrigel Basement Membrane Matrix. Equal number of 
cells (2.5*104) were seeded into the upper chamber of the transwell and allowed to migrate 
for 72 h. The lower chamber additionally contained HGF (100 ng/mL). Cells were fixed 
with 4% paraformaldehyde for 10 min, washed with PBS and stained with TRITC 
phalloidin. Cells were analyzed by serial confocal Z sections, taken from the top of the 
matrigel to the bottom of the supporting plastic porous filter. The number of cells was 
counted in four randomly chosen fields. Data are expressed as the mean +/- s.e.m. of three 
independent experiments. 
6.5.6 MHC class I recycling 
si CTR and si NUMB HeLa cells, upon 48h of interference, were washed twice with PBS, 
and incubated at 16°C for 3h in, CO2-independent, L-15 medium Leibovitz (Gibco), 
supplemented with 10% FBS, containing 10 µg/mL of mouse MHC I antibody (sc-32235). 
Under these conditions, recycling is blocked, whereas internalization proceeds, albeit at a 
reduced rate(Punnonen, Ryhanen, and Marjomaki 1998). The cells were washed twice with 
ice-cold PBS, three times with acid wash buffer (0.5M NaCl, 0.5 M acetic acid, pH 2.5), 
followed by successive rinses with PBS to remove surface antibody and complete medium 
was added. The cells were then transferred to 37°C to allow recycling of internalized MHC 
I. At various time points, cells were harvested on ice in PBS 10 mM EDTA, transferred in 
a clean tube and washed once in PBS 1% BSA. Pellet was incubated with secondary 
antibody resuspended in PBS 1% BSA. Cells were washed three times with PBS 1% BSA. 
Cells were fixed in 2% formaldeahyde for 20’ on ice. Cells were washed once in PBS 1% 
BSA, resuspendend in PBS and kepped at 4C until FACS analysis. The amount of MHC 
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class I recycled at different time points was calculated as percentage of total MHC class I 
internalized at time 0 (t0). 
6.5.7 In situ proximity ligation assay (PLA) 
We detected the association in situ between NUMB-FLAG and GFP-EFA6B with a 
Duolink II detection kit (Olink Bioscience), according to the manufacturer’s instructions. 
Upon fixation in 4%PFA, cells were incubated 10’ with blocking solution (PBS, 0.1 % 
Tween 20, 1% BSA). Primary antibodies against FLAG and GFP were incubated in the 
presence of blocking solution (PBS, 0.05 Tween 20, 1% BSA). This was followed by 
incubation with secondary antibodies conjugated to oligonucleotides that are ligated to 
form a closed circle in the presence of Duolink Ligation Solution(Soderberg et al. 2006). In 
the final step, we added DNA polymerase in order to amplify ligated oligos, which were 
detected using complementary, fluorescently labeled oligonucleotides.  
6.6 Biochemical procedures 
6.6.1 SDS polyacrylamide gel electrophoresis (SDS PAGE) 
Gels for resolution of proteins were made from a 30%, 37.5:1 mix of 
acrylamide:bisacrylamide (Sigma). As polymerisation catalysts, 10% ammonium 
persulphate (APS) and TEMED (Fluka) were used. 
6.6.2 Western blot 
Desired amounts of proteins were loaded onto 0.75-1.5 mm thick polyacrylamide gels for 
electrophoresis (Biorad). Proteins were transferred in Western transfer tanks (Biorad) to 
nitrocellulose (Schleicher and Schuell) in Western Transfer buffer 1x (diluted in 20% 
methanol) at constant Voltage (100V for 1 hour or 30V overnight). PonceauS colouring 
was used to reveal roughly the amount of proteins transferred on the filters. Filters were 
blocked 1 hour (or overnight) in 5% milk or 5% BSA in TBS 0.1% Tween (TBS-T). 
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After blocking, filters were incubated with the primary antibody, diluted in TBS-T 5% 
milk, for one hour at room temperature, or overnight at 4˚C, followed by three washes of 
five minutes each in TBS-T and then incubated with the appropriate peroxidase-conjugated 
secondary antibody diluted in TBS-T for 1 hour. After the incubation with the secondary 
antibody, the filter was washed three times in TBS-T and the bound secondary antibody 
was revealed using the ECL (Enhanced Chemiluminescence) method (Amersham).  
6.6.3 Co-immunoprecipitation assay 
Lysates prepared in JS buffer were incubated in the presence the anti FLAG M2 affinity 
gel (a purified murine IgG1 monoclonal antibody covalently attached to agarose, Sigma 
Aldrich) for two cycles of 1 h each at 4°C with rocking. 
Immunoprecipitates were then washed 3 times in JS buffer. After washing, beads were 
resuspended in 1:1 volume of 2x SDS-PAGE Sample Buffer, boiled for 10 min at 95°C, 
centrifuged for 1 minute and then loaded onto polyacrylamide gels. 
6.6.4 Pull-down assay  
Lysates prepared in JS buffer were incubated in the presence of 0.5 µM of GST tagged 
purified proteins immobilized on beads for 1 h at 4°C under mild agitation. 
Beads were then washed 3 times in JS buffer. After washing, beads were resuspended in 
1:1 volume of 2x SDS-PAGE Sample Buffer, boiled for 10 min at 95°C, centrifuged for 1 
minute and then loaded onto polyacrylamide gels. 
6.6.5 In vitro binding assay 
0.5 µM of purified proteins immobilized on beads were incubated with indicated amount 
of purified protein in JS buffer for 1h at 4°C under mild agitation. 
Beads were then washed 3 times in JS buffer. After washing, beads were resuspended in 
1:1 volume of 2x SDS-PAGE Sample Buffer, boiled for 10 min at 95°C, centrifuged for 1 
minute and then loaded onto polyacrylamide gels. 
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6.6.6 GST-fusion and His-fusion proteins production 
All the GST and His fusion proteins used were product in bacteria using E. coli BL21 
Rosetta (DE3) competent cells transformed with the pGEX6P1 or pET30 vector in which 
the desired construct had been cloned. 
6.6.6.1 Bacterial culture 
E. coli BL21 Rosetta (DE3) cells picked from individual colonies, transformed with the 
indicated GST-fusion or His-fusion constructs, were used to inoculate 200 mL of LB 
medium (containing ampicillin at 50 µg/mL) and were grown overnight at 37°C. Between 
10 and 100 mL of the overnight culture was diluted in 1 litre of LB and was grown at 37°C 
(240 rpm shaking) till it reached approximately OD=0.4-0.6.  
Then IPTG was used to induce the protein production using different conditions depending 
on the protein: 
Construct IPTG concentration Time Temperature 
GST NUMB FL, PTB, PRR1, PRR2 0.3mM 6-8 h 18°C 
GST EFA6B 1-738 aa 0.2mM o/n 18°C 
GST PTB EPS8 0.3mM 3h 37°C 
GST 1mM 3h 37°C 
His NUMB FL and PTB 0.1 mM 3h 30°C 
After the induction cells were pelleted down at 6000 rpm for 15 minutes at 4°C and pellets 
were used immediately or conserved at -80°C after washing in PBS 1X. 
6.6.6.2 Protein production 
Pellets were suspended in GST-lysis buffer or His-lysis buffer based on the tag (15mL for 
1L culture). Samples were sonicated 3 times for 30 seconds/each on ice and were pelleted 
down at 13200 rpm for 30 minutes at 4°C using a JA 20 Beckman rotor or at 40000 rpm 
for 45 minutes at 4°C using a 55.2 Ti Beckman rotor. 1 mL of glutathione-sepharose beads 
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(Amersham) or 5 mL of Ni-NTA (Qiagen), previously washed 3 times with GST-lysis 
buffer or His lysis buffer respectively, was added to the surnatant and samples were 
incubated 1-2 hour at 4°C while rocking. Beads were then washed 3 times (with 5 minutes 
of incubation at 4°C each) in the GST or His lysis solution. GST-proteins were 
resuspendend 50% slurry in the GST-lysis solution. The quantification was achieved in an 
SDS PAGE gel using a titration curve with BSA. 
 GST-lysis buffer 
 2x TBS 
 0.5 mM EDTA 
10% Glycerol 
 protease inhibitor cocktail (Roche, Basel, Switzerland) (freshly added) 
 1 mM DTT  (freshly added) 
His-lysis buffer 
 2x TBS 
 2 mM ß-mercaptoehanol 
10% Glycerol 
 protease inhibitor cocktail (Roche, Basel, Switzerland) (freshly added) 
 20 mM Imidazole 
6.6.6.3 Numb His-fusion protein elution 
Beads were washed once in the washing solution and than subjected to six cycles of elution 
in the elution buffer in Poly-Prep Chromatography columns (Biorad). Eluted proteins were 
collected in clean tubes containing 1mM EDTA and 1 mM DTT. The best fraction 
identified in SDS-PAGE gel were collected together and dialyzed overnight in dialysis 
buffer. After dialysis, precipitates were removed by centrifugation and the surnatant was 
diluted to have finally 40 mM NaCl and purified through ion exchange chromatography 
using a Resource Q column (GE Healthcare Life Science), on an AKTA purifier system 
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(Amersham Bioscience). The fractions in the area under the curve were collected together, 
concentrated with Vivaspin concentrators (Vivaspin 20 MWCO 100000, Sartorius Stedim 
Biotech), flesh frozen using liquid Nitrogen and stored at -80˚C. 
Washing buffer 
1X TBS 
50 mM Imidazole 
10% Glycerol 
Elution buffer 
1X TBS 
200 mM Imidazole  
10% Glycerol 
Dialysis and storage buffer 
20 mM Tris pH 7.1 
10% Glycerol 
0.5 mM EDTA 
1mM DTT 
160 mM NaCl 
6.6.6.4 Numb PTB His-fusion protein elution 
Beads were washed once in the washing solution and than subjected to six cycles of elution 
in the elution buffer in Poly-Prep Chromatography columns (Biorad). Eluted proteins were 
collected in clean tubes containing 1mM EDTA and 1 mM DTT. The best fraction 
identified in SDS-PAGE gel were collected together and dialyzed overnight in dialysis 
buffer. After dialysis, precipitates were removed by centrifugation and the surnatant was 
concentrated in Vivaspin concentrators (Vivaspin 20 MWCO 3000, GE Healthcare Life 
Science) and purified through gel filtration using a Superdex 200 10\30 column (GE 
Healthcare Life Science), equilibrated with storage buffer, on an AKTA purifier system 
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(Amersham Bioscience). Proteins were loaded in 500 µl volume using a Hamilton syringe. 
Typical flow rate was 0.5 mL\min. Finally, the fractions in the area under the curve were 
collected together, concentrated with Vivaspin concentrators (Vivaspin 20 MWCO 
100000, Sartorius Stedim Biotech), flesh frozen using liquid Nitrogen and stored at -80˚C. 
Washing buffer 
1X TBS 
50 mM Imidazole 
Elution buffer 
1X TBS 
200 mM Imidazole  
Dialysis buffer 
1X TBS 
0.5 mM EDTA 
1mM DTT 
Storage buffer 
20 mM Tris pH 7.6 
5% Glycerol 
10 mM NaCl 
0.5 mM EDTA 
1 mM DTT 
6.6.7 MBP EFA6B protein production 
The MBP EFA6B protein used was produced in Baculovirus system. EFA6B was cloned in 
pBAC_His-MBP-TEV vector. 
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6.6.7.1 Transposition 
Transposition was made using DH10MultiBac-YFP electro competent cells (a gift from A. 
Musacchio) that were electroporeted in presence of 1 µl of DNA from average yeld 
miniprep. 
Selection of the recombinant bacteria was made after plating on LB plates containing 50 
µg/mL kanamycin, 7 µg/mL gentamycin, 10 µg/mL tetracycline, 200 µg/mL X-gal, 40 
µg/mL IPTG at least 48 hours. 
White recombinant proteins were selected and bacmid DNA was isolate using the 
Promega, Wizard Plus SV Minipreps kit with a slight protocol modification. Because the 
bacmid DNA is to big to be eluted the kit columns, DNA was extracted using isopropanol 
precipitation.  
6.6.7.2 Virus production 
The DNA was used then to transfect Sf21 insect cells (Invitrogen) in order to produce the 
virus. Sf21 cells were plated at 0.5*106/mL in a six well plate and transfected using 
Insectogene reagent (Biontex Laboratories), according to manufacturer’s instruction. Cells 
transfection was monitored looking at the appearance of YFP positive cells. After 72 hours 
the surnatant was collected (this was the V0, primary stock virus production). The virus 
was amplified in H5 cells (Invitrogen). 25 mL of H5 cells at 0.5*106/mL were infected 
using 1.5 mL of the V0 virus. Cells infection was monitored looking at appearance if YFP 
positive cells and at the cells growth arrest that is caused by the viral infection. After 72 
hours from the cell growth arrest the surnatant was collected (this is the V1 generation). 
The virus was amplified a second time using 200 mL of H5 cells infected with 2.5 mL of 
the V1 virus, following the same protocol. 
6.6.7.3 Protein production 
Protein production was finally made following the same protocol but starting from 500 mL 
of H5 cells at 0.5*106 cells/mL infected with 12.5 mL of V2 virus. 
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For protein purification the cells were harvested three days after infection. After 15 
minutes centrifugation at 1200 rpm Pellets were suspended in lysis buffer (25mL for 1L 
culture) or conserved at -80 °C after washing in PBS1X. Samples were sonicated 3 times 
for 30 seconds/each on ice and were pelleted down at 45000 rpm for 1 hour at 4°C using a 
55.2 Ti Beckman rotor. 1 mL of amylose beads (NEB), previously washed 3 times with 
lysis buffer, was added to the surnatant and samples were incubated 1-2 hour at 4°C while 
rocking. Beads were then washed 3 times (with 5 minutes of incubation at 4°C each) lysis 
solution.  
 Lysis solution 
 2x TBS 
 0.5 mM EDTA 
10% Glycerol 
 protease inhibitor cocktail (Roche, Basel, Switzerland) (freshly added) 
 1 mM DTT  (freshly added) 
6.6.7.4 MBP EFA6B protein elution 
Beads were washed once in the lysis solution and than subjected to six cycles of elution in 
the elution buffer in Poly-Prep Chromatography columns (Biorad). Eluted proteins were 
collected in clean tubes. The best fraction identified in SDS-PAGE gel were collected 
together and dialyzed overnight in dialysis buffer. After dialysis precipitates were removed 
by centrifugation and the surnatant was concentrated in Vivaspin concentrator (Vivaspin 
20 MWCO 100000, Sartorius Stedim Biotech), flesh frozen using liquid Nitrogen and 
stored at –80˚C. 
Elution buffer 
 2X TBS 
10% Glycerol  
10 mM Amylose 
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0.5 mM EDTA 
1 mM DTT  (freshly added) 
Dialysis and storage buffer 
1X TBS 
10% Glycerol 
0.5 mM EDTA 
1mM DTT 
6.7 Statistical analysis 
In the CDR formation assay 20 fields were analyzed for each sample and the percentage of 
cells forming CDRs (number of cells with CDRs/total number of cells in the field) was 
scored. In case of re-infection with GFP constructs, only GFP-positive cells were 
considered for the analysis. All data are presented as the mean±standard errors of mean 
(s.e.m.) from at least three independent experiments. 
A Student’s t-test was used to calculate the P-values. 
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